<HTML>
<HEAD>
<TITLE>Form S-8</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>As
filed with the Securities and Exchange Commission on July&nbsp;7, 2010</B>
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 10pt"><B>Registration No.&nbsp;333-________</B>
</DIV>


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 10pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>WASHINGTON, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 10pt"><B><DIV align="center"><DIV style="font-size: 6pt; margin-top: 20pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 10pt"><B>FORM S-8</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 10pt"><B>REGISTRATION STATEMENT<BR>
UNDER THE SECURITIES ACT OF 1933</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 10pt"><B><DIV align="center"><DIV style="font-size: 6pt; margin-top: 20pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></B>
</DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 10pt"><B>VERINT SYSTEMS INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center" style="font-size: 10pt"><DIV align="center"><DIV style="font-size: 6pt; margin-top: 20pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="48%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B><BR>
(State or other jurisdiction of incorporation or organization)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>11-3200514</B><BR>
(I.R.S. Employer Identification No.)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>330 South Service Road, Melville, New York</B><BR>
(Address of Principal Executive Offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>11747</B><BR>
(Zip Code)</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><DIV align="center"><DIV style="font-size: 6pt; margin-top: 20pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>VERINT SYSTEMS INC. STOCK INCENTIVE COMPENSATION PLAN<BR>
VERINT SYSTEMS INC. 2004 STOCK INCENTIVE COMPENSATION PLAN<BR>
WITNESS SYSTEMS, INC. AMENDED AND RESTATED STOCK INCENTIVE PLAN</B><BR>
(Full title of the plan)</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><DIV align="center"><DIV style="font-size: 6pt; margin-top: 20pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>Peter Fante<BR>
Chief Legal Officer<BR>
Verint Systems Inc.<BR>
330 South Service Road<BR>
Melville, New York 11747</B><BR>
(Name and address of agent for service)</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>(631)&nbsp;962-9600</B><BR>
(Telephone number, including area code, of agent for service)</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B><I>With copies to:</I></B><BR>
Randi C. Lesnick, Esq.<BR>
Jones Day<BR>
222 East 41<SUP style="font-size: 85%; vertical-align: text-top">st</SUP> Street<BR>
New York, New York 10017<BR>
(212)&nbsp;326-3939</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of &#147;large accelerated
filer,&#148; &#147;accelerated filer&#148; and &#147;smaller reporting company&#148; in Rule&nbsp;12b-2 of the Exchange Act.
(Check one):
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="left" valign="top" nowrap>Large accelerated filer <FONT face="Wingdings">&#111;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" nowrap>Accelerated filer <FONT face="Wingdings">&#254;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" nowrap>Non-accelerated filer <FONT face="Wingdings">&#111;</FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" nowrap>Smaller reporting company <FONT face="Wingdings">&#111;</FONT></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><FONT style="white-space: nowrap">(Do not check if a smaller reporting company)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>CALCULATION OF REGISTRATION FEE</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="46%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>

    <TD width="1%">&nbsp;</TD>
</TR><TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="23" style="border-bottom: 3px double #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD>&nbsp;</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Proposed Maximum</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Proposed Maximum</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="left">Title of Securities to be</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Amount to be</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Offering Price Per</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Aggregate Offering</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Amount of</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="left">Registered</TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Registered<SUP style="font-size: 85%; vertical-align: text-top">(1)(2)</SUP></TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Share<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP></TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Price<SUP style="font-size: 85%; vertical-align: text-top">(3)</SUP></TD>
    <TD style="border-right: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">Registration Fee</TD>
    <TD width="1%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD width="1%" style="border-top: 1px solid #000000">&nbsp;</TD>
                    <TD style="border-top: 1px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock, $0.001 par
value per share</DIV></TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 1px solid #000000">1,813,134</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 1px solid #000000"><B>&nbsp;</B></TD>
    <TD align="center" style="border-top: 1px solid #000000">$23.15</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 1px solid #000000">$41,974,052.10</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-right: 1px solid #000000; border-top: 1px solid #000000">&nbsp;</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD align="right" style="border-top: 1px solid #000000">$2,992.75</TD>
    <TD style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD width="1%" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="23" style="border-top: 3px double #000000">&nbsp;</TD>
</TR>

<!-- End Table Body --></TABLE>
</DIV>




<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR style="font-size: 6pt">
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="96">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">(1)</TD>
    <TD>&nbsp;</TD>
    <TD>Pursuant to Rule&nbsp;416 under the Securities Act of 1933 (the &#147;Securities Act&#148;), this
Registration Statement shall include any additional shares of common stock, par value $0.001
per share (the &#147;Common Stock&#148;), that may become issuable as a result of stock splits, stock
dividends or similar transactions.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(2)</TD>
    <TD>&nbsp;</TD>
    <TD>Represents 157,086 shares of Common Stock previously issued pursuant to the Verint Systems
Inc. Stock Incentive Compensation Plan, as amended to be registered for resale; 1,250,024 shares
of Common Stock previously issued pursuant to the Verint Systems Inc. 2004 Stock
Incentive Compensation Plan, as amended, to be registered for resale; and 406,024 shares of
Common Stock previously issued pursuant to the Witness Systems, Inc. Amended and Restated
Stock Incentive Plan, as amended, to be registered for resale. The Common Stock has been
previously issued to officers, directors or employees.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(3)</TD>
    <TD>&nbsp;</TD>
    <TD>Estimated solely for the purpose of calculating the amount of the registration fee pursuant
to Rule&nbsp;457(c) under the Securities Act, based on the average of the high and low prices of
our Common Stock as reported by the NASDAQ Global Market on July&nbsp;6, 2010.</TD>
</TR>

</TABLE>

<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>



<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">





<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>EXPLANATORY NOTE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">This Registration Statement contains two parts. The first part contains a resale prospectus
prepared in accordance with the requirements of General Instruction&nbsp;C to Form&nbsp;S-8 that covers
resales of &#147;restricted securities&#148; and &#147;control securities&#148; (in each case, as defined in General
Instruction&nbsp;C to Form&nbsp;S-8). This resale prospectus relates to shares of common stock, $0.001 par
value per share, of Verint Systems Inc. (the &#147;Company&#148;) previously issued to certain officers,
directors and employees of the Company pursuant to the Verint Systems Inc. Stock Incentive
Compensation Plan, as amended; the Verint Systems Inc. 2004 Stock Incentive Compensation Plan, as
amended; and the Witness Systems, Inc. Amended and Restated Stock Incentive Plan. The second part
of this Registration Statement contains Information Required in the Registration Statement pursuant
to Part&nbsp;II of Form&nbsp;S-8.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 8%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>REOFFER PROSPECTUS</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>VERINT SYSTEMS INC.</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>1,813,134 SHARES OF COMMON STOCK</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">This prospectus relates to the resale, from time to time, of up to 1,813,134 shares of our
common stock, $0.001 par value per share, by the selling stockholders listed in this prospectus.
The selling stockholders acquired such shares pursuant to grants made under (1)&nbsp;the Verint Systems
Inc. Stock Incentive Compensation Plan, as amended; (2)&nbsp;the Verint Systems Inc. 2004 Stock
Incentive Compensation Plan, as amended; or (3)&nbsp;the Witness Systems, Inc. Amended and Restated
Stock Incentive Plan, as amended. The Verint Systems Inc. Stock Incentive Compensation Plan, as
amended; the Verint Systems Inc. 2004 Stock Incentive Compensation Plan, as amended; and the
Witness Systems, Inc. Amended and Restated Stock Incentive Plan, as amended, are collectively
referred to in this prospectus as the &#147;Plans.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">We will not receive any proceeds from sales of the shares of our common stock covered by this
prospectus by any of the selling stockholders. The shares may be offered, from time to time, by
any or all of the selling stockholders through ordinary brokerage transactions, in negotiated
transactions or in other transactions, at such prices as he, she or they may determine, which may
relate to market prices prevailing at the time of sale or be a negotiated price. See &#147;Plan of
Distribution.&#148; We will bear all costs, expenses and fees in connection with the registration of
the shares. Brokerage commissions and similar selling expenses, if any, attributable to the offer
or sale of the shares will be borne by the selling stockholders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Each selling stockholder and any broker executing selling orders on behalf of a selling
stockholder may be deemed to be an &#147;underwriter&#148; as defined in the Securities Act of 1933, as
amended, or the Securities Act. If any broker-dealers are used to effect sales, any commissions
paid to broker-dealers and, if broker-dealers purchase any of the shares of common stock covered by
this prospectus as principals, any profits received by such broker-dealers on the resales of shares
may be deemed to be underwriting discounts or commissions under the Securities Act. In addition,
any profits realized by the selling stockholders may be deemed to be underwriting commissions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Shares of our common stock are listed on the NASDAQ Global Market under the symbol &#147;VRNT.&#148; On
July&nbsp;6, 2010, the last reported sale price of our common stock
was $23.80 per share.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><B>Investing in shares of our common stock involves a high degree of risk. See &#147;Risk Factors&#148; on
page&nbsp;4 of this prospectus and the other risk factors set forth in our periodic and other filings
with the Securities and Exchange Commission, or the SEC, including those set forth in our Annual
Report on Form&nbsp;10-K for the year ended January&nbsp;31, 2010, for a discussion of certain factors
that should carefully be considered by prospective purchasers.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><B>Neither the SEC nor any state securities commission has approved or disapproved of these
securities or determined if this prospectus is truthful or complete. Any representation to the
contrary is a criminal offense.</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt">This
prospectus is dated July&nbsp;7, 2010.
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">


<DIV align="left">
<!-- TOC -->
</DIV>
<DIV align="left">
<A name="tocpage"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>TABLE OF CONTENTS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="92%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#101">Prospectus Summary</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#102">Cautionary Note on Forward-Looking Statements</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#103">Risk Factors</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#104">Use of Proceeds</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#105">Selling Stockholders</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#106">Plan of Distribution</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#107">Legal Matters</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#108">Experts</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#109">Information Incorporated by Reference</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#110">Where You Can Find Additional Information</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="c03128exv5w1.htm">Exhibit 5.1</A></FONT></TD></TR>
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="c03128exv23w1.htm">Exhibit 23.1</A></FONT></TD></TR>
</TABLE>
</DIV>

<DIV align="left">
<!-- /TOC -->
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">You should rely only on the information contained in or incorporated by reference into this
prospectus. We have not authorized any other person to provide you with additional information or
information different from that contained in or incorporated by reference into this prospectus.
The selling stockholders may, from time to time, offer to sell shares of our common stock only in
jurisdictions where the offer or sale is permitted. You should not assume that the information
contained in this prospectus is accurate as of any date other than the date on the front cover of
this prospectus or that the information contained in any document incorporated by reference into
this prospectus is accurate as of any date other than the date of the document incorporated by
reference.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 8%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->i<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV style="margin-top: 18pt; width: 100%; padding: 11px; background-color: FFFFFF; border-top: 1pt solid black; font-size: 1pt; border-bottom: 1pt solid black; font-size: 1pt; border-left: 1pt solid black; font-size: 1pt; border-right: 1pt solid black; font-size: 1pt">
<DIV align="left">
<A name="101"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>PROSPECTUS SUMMARY</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><I>This summary highlights information contained elsewhere in or incorporated by reference into
this prospectus. This summary is not complete and does not contain all of the information that may
be important to you and that you should consider before investing in shares of our common stock.
You should carefully read the entire prospectus, including the section titled &#147;Risk Factors,&#148; and
the other information incorporated by reference into this prospectus before making an investment
decision.</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><I>References in this prospectus to the terms &#147;Verint,&#148; &#147;the Company,&#148; &#147;we,&#148; &#147;us&#148; and &#147;our,&#148; or
other similar terms, mean Verint Systems Inc., together with its consolidated subsidiaries, unless
the context indicates otherwise.</I>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>VERINT SYSTEMS INC.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">We are a global leader in Actionable Intelligence<SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP> solutions and value-added services. Our
solutions enable organizations of all sizes to make timely and effective decisions to improve
enterprise performance and make the world a safer place. More than 10,000 organizations in over 150
countries&#151;including over 80% of the Fortune 100&#151;use Verint solutions to capture, distill and
analyze complex and underused information sources, such as voice, video and unstructured text.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">In the enterprise market, our workforce optimization solutions help organizations enhance
customer service operations in contact centers, branches and back-office environments to increase
customer satisfaction, reduce operating costs, identify revenue opportunities and improve
profitability. In the security intelligence market, our video intelligence, public safety and
communications intelligence solutions are vital to government and commercial organizations in their
efforts to protect people and property and neutralize terrorism and crime.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Headquartered in Melville, New York, we support our customers around the globe directly and
with an extensive network of selling and support partners. Our principal executive offices are
located at 330 South Service Road, Melville, New York 11747, our telephone number is (631)&nbsp;962-9600
and our website address is www.verint.com. Information contained on our website is not a part of
this prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">&nbsp;<BR>&nbsp;<BR>&nbsp;<BR>&nbsp;
</DIV>

</DIV>
<!-- nbsp -->

<P align="center" style="font-size: 10pt; text-indent: 8%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">
<DIV align="left">
<A name="102"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Certain statements discussed in this prospectus constitute &#147;forward-looking statements&#148; within
the meaning of the Private Securities Litigation Reform Act of 1995, the provisions of Section&nbsp;27A
of the Securities Act and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended, or the
Exchange Act (which Sections were adopted as part of the Private Securities Litigation Reform Act
of 1995). Forward-looking statements include financial projections, statements of plans and
objectives for future operations, statements of future economic performance and statements of
assumptions relating thereto. Forward-looking statements are often identified by future or
conditional words such as &#147;will,&#148; &#147;plans,&#148; &#147;expects,&#148; &#147;intends,&#148; &#147;believes,&#148; &#147;seeks,&#148; &#147;estimates&#148;
or &#147;anticipates,&#148; by variations of such words or by similar expressions. There can be no assurances
that forward-looking statements will be achieved. By their very nature, forward-looking statements
involve known and unknown risks, uncertainties and other important factors that could cause our
actual results or performance to differ materially from those expressed or implied by such
forward-looking statements. Important risks, uncertainties and other factors that could cause our
actual results or performance to differ materially from our forward-looking statements include, among others:
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risks relating to the filing of our SEC reports, including the occurrence of
known contingencies or unforeseen events that could delay our filings, management
distractions, and significant expense;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risk associated with the SEC&#146;s initiation of an administrative proceeding on
March&nbsp;3, 2010 to suspend or revoke the registration of our common stock under the
Exchange Act due to our previous failure to file an annual report on either Form
10-K or Form 10-KSB since April&nbsp;25, 2005 or quarterly reports on either Form 10-Q
or Form 10-QSB since December&nbsp;12, 2005;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risk that our credit rating could be downgraded or placed on a credit watch
based on, among other things, our financial results, delays in the filing of our
periodic reports, or the results of the SEC&#146;s administrative proceeding;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risks associated with being a consolidated, controlled subsidiary of Comverse
Technology, Inc., or Comverse, and formerly part of Comverse&#146;s consolidated tax
group, including risk of any future impact on us resulting from Comverse&#146;s special
committee investigation and restatement or related effects, and risks related to
our dependence on Comverse to provide us with accurate financial information,
including with respect to stock-based compensation expense and net operating loss
carryforwards, or NOLs, for our financial statements;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>uncertainty regarding the impact of general economic conditions, particularly in
information technology spending, on our business;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risk that our financial results will cause us not to be compliant with the
leverage ratio covenant under our credit facility or that any delays in the filing
of future SEC reports could cause us not to be compliant with the financial
statement delivery covenant under our credit facility;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risk that customers or partners delay or cancel orders or are unable to honor
contractual commitments due to liquidity issues, challenges in their business or
otherwise;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risk that we will experience liquidity or working capital issues and related
risk that financing sources will be unavailable to us on reasonable terms or at
all;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>uncertainty regarding the future impact on our business of our internal
investigation, restatement, extended filing delay, and the SEC&#146;s administrative
proceeding, including customer, partner, employee, and investor concern, and
potential customer and partner transaction deferrals or losses;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risks relating to the remediation or inability to adequately remediate material
weaknesses in our internal controls over financial reporting and relating to the
proper application of highly complex accounting rules and pronouncements in order
to produce accurate SEC reports on a timely basis;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risks relating to our implementation and maintenance of adequate systems and
internal controls for our current and future operations and reporting needs;</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV style="margin-top: 10pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risk of possible future restatements if the processes used to produce the
financial statements contained in our SEC reports are inadequate;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risk associated with current or future regulatory actions or private litigations
relating to our internal investigation, restatement or previous delay in timely making
required SEC filings;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risk that we will be unable to maintain the listing of our common stock on the
NASDAQ Global Market;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risks associated with Comverse controlling our board of directors and a majority
of our common stock (and therefore the results of any significant stockholder
vote);</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risks associated with significant leverage, resulting from our current debt
position;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risks due to aggressive competition in all of our markets, including with
respect to maintaining margins and sufficient levels of investment in the business
and with respect to introducing quality products which achieve market acceptance;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risks created by continued consolidation of competitors or introduction of large
competitors in our markets with greater resources than us;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risks associated with significant foreign and international operations,
including exposure to fluctuations in exchange rates;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risks associated with complex and changing local and foreign regulatory
environments;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risks associated with our ability to recruit and retain qualified personnel in
all geographies in which we operate;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>challenges in accurately forecasting revenue and expenses;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risks associated with acquisitions and related system integrations;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risks relating to our ability to improve our infrastructure to support growth;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risks that our intellectual property rights may not be adequate to protect our
business or that others may make claims on our intellectual property or claim
infringement on their intellectual property rights;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risks associated with a significant amount of our business coming from domestic
and foreign government customers;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risk that we improperly handle sensitive or confidential information or
perception of such mishandling;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risks associated with dependence on a limited number of suppliers for certain
components of our products;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risk that we are unable to maintain and enhance relationships with key
resellers, partners and systems integrators; and</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>risk that use of our NOLs or other tax benefits may be restricted or eliminated
in the future.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">
You should carefully review the section entitled &#147;Risk Factors&#148; beginning on page&nbsp;4 of this
prospectus and the other risk factors set forth in our periodic and other filings with the SEC,
including those set forth in our Annual Report on Form&nbsp;10-K for the year ended January&nbsp;31,
2010, for a discussion of these and other risks that relate to our business and an investment in
shares of our common stock. Investors are cautioned not to place undue reliance on forward-looking
statements, which reflect our management&#146;s view only as of the date of such statements.
We make no commitment to revise or update any forward-looking statements in order to reflect
events or circumstances after the date any such statement is made, except as otherwise required
under the federal securities laws. If we were in any particular instance to update or correct a
forward-looking statement, investors and others should not conclude that we would make additional
updates or corrections thereafter except as otherwise required under the federal securities laws.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 8%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">
<DIV align="left">
<A name="103"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>RISK FACTORS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%"><I>Investing in shares of our common stock involves a high degree of risk. You should carefully
review the risks described below and the other risk factors set forth in our periodic and other
filings with the SEC, including those set forth in our Annual Report on </I><I>Form 10-K</I><I> for the
year ended January&nbsp;31, 2010, together with the other information contained in and incorporated by
reference into this prospectus, before making an investment decision. Our business, results of
operations and financial condition may be materially and adversely affected due to any of these
risks. The trading price of our shares could decline due to any of these risks, and you could lose
all or part of your investment. Some risk factors in this section are &#147;forward-looking
statements.&#148; See &#147;Cautionary Note on Forward-Looking Statements.&#148;</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Risks Relating To Our Common Stock</B>
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%"><B><I>We may not pay dividends on our common stock for the foreseeable future.</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">We intend to retain our earnings to support the development and expansion of our business, to
repay debt and for other corporate purposes and, as a result, we do not plan to pay cash dividends
on our common stock in the foreseeable future. Our payment of any future dividends will be at the
discretion of our board of directors after taking into account various factors, including our
financial condition, operating results, cash needs, growth plans and the terms of any credit
facility or other restrictive debt agreements that we may be a party to at the time or senior
securities we may have issued. Our current credit facility limits us from paying cash dividends or
other payments or distributions with respect to our capital stock. In addition, the terms of any
future facility or other restrictive debt credit agreement may contain similar restrictions on our
ability to pay any dividends or make any distributions or payments with respect to our capital
stock. In addition, holders of our outstanding preferred stock are entitled to cumulative dividends
before any dividends may be declared or set aside on our common stock.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Furthermore, our ability to pay dividends to our stockholders is subject to the restrictions
set forth under Delaware law. We cannot assure you that we will meet the criteria specified under
Delaware law in the future, in which case we may not be able to pay dividends on our common stock
even if we were to choose to do so.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%"><B><I>The price of our common stock fluctuates significantly, and this may make it difficult for you
to resell the common stock when you want to or at prices you find attractive.</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">There has been significant volatility in the market price and trading volume of equity
securities, including our common stock, some of which is unrelated to the financial performance of
the companies issuing the securities. The price for the shares of common stock being sold under
this prospectus may not be indicative of prices that will prevail in the open market following your
purchase of such shares. You may not be able to resell your shares at or above the price you paid
due to fluctuations in the market price of our common stock caused by changes in our operating
performance or prospects and other factors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Some specific factors that may have a significant effect on our common stock market price
include:
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>actual or anticipated quarterly fluctuations in our operating and financial
results;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>developments related to investigations, proceedings or litigation that involve
us;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>changes in financial estimates and recommendations by financial analysts;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>dispositions, acquisitions, and financings;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>actions of our current stockholders, including sales of our common stock by
existing stockholders and our directors and executive officers;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>success of competitive service offerings or technologies;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>fluctuations in the stock price and operating results of our competitors;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>investors&#146; general perception of us;</TD>
</TR>

</TABLE>
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV style="margin-top: 10pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>regulatory developments; and</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>developments related to the industries in which we compete.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Because our common stock has only been re-listed on the NASDAQ Global Market since July&nbsp;6,
2010, we cannot predict the extent to which investor interest in our company will lead to the
development of an active trading market on the NASDAQ Global Market or otherwise or how liquid that
market might become. Unless there is an active trading market for our common stock, you may have
difficulty selling any of our common stock that you purchase. Consequently, you may not be able to
sell our common stock at prices equal to or greater than the price you paid.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%"><B><I>If we or our stockholders sell substantial amounts of our common stock following the sale of the
shares of common stock being sold under this prospectus, the market price of our common stock
may decline.</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">
We are not restricted from issuing additional shares of common stock, including shares
issuable pursuant to securities that are convertible into or exchangeable for, or that represent
the right to receive, common stock. Sales of shares of our common stock in the public market
following the sale of the shares of common stock being sold under this prospectus, or the
perception that these sales may occur, could cause the market price of our common stock to decline.
We had 33,042,345 shares of common stock outstanding as of
June&nbsp;30, 2010. In addition, at June&nbsp;30, 2010, 8,916,086
shares of our common stock (including 1,269,894 of the shares included in this prospectus
which were acquired by the selling stockholders on July&nbsp;2, 2010
and July&nbsp;6, 2010) were issuable pursuant to outstanding stock
options and awards which had
not yet vested or which had been previously acquired upon vesting but had not yet been delivered.
Moreover, if it were convertible at June&nbsp;30, 2010, our outstanding preferred stock could be
converted into 10,072,966 shares of our common stock. Additional shares of common stock underlying
options and restricted stock units available to be granted in the
future will become available for sale in the public market.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">In addition,
under two registration rights agreements that we entered into with Comverse,
Comverse has registration rights, with respect to its common stock and preferred stock,
and future offerings of our common stock could result in sales
of significant amounts of our common stock.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%"><B><I>Anti-takeover provisions in Delaware corporate law may make it difficult for our stockholders to
replace or remove our current board of directors and could deter or delay third-parties from
acquiring us, which may adversely affect the marketability and market price of our common stock.</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">We are subject to the anti-takeover provisions of Section&nbsp;203 of the Delaware General
Corporation Law. Under these provisions, if anyone becomes an &#147;interested stockholder,&#148; we may not
enter into a &#147;business combination&#148; with that person for three years without special approval,
which could discourage a third party from making a takeover offer and could delay or prevent a
change of control. For purposes of Section&nbsp;203, &#147;interested stockholder&#148; means, generally, someone
owning more than 15% or more of our outstanding voting stock or an affiliate of ours that owned 15%
or more of our outstanding voting stock during the past three years, subject to certain exceptions
as described in Section&nbsp;203.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Under any change of control, the lenders under our credit facilities would have the right to
require us to repay all of our outstanding obligations under the facility. Upon the occurrence of a
&#147;Fundamental Change&#148;, as defined by the Certificate of Designation setting forth the terms of the
preferred stock, and which includes a change of control, the holders of our preferred stock have
the right to require us to repurchase their shares of preferred stock at the then current
liquidation preference (subject to certain exceptions set forth in the Certificate of Designation).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%"><B><I>Holders of our preferred stock have liquidation and other rights that are senior to the rights
of the holders of our common stock.</I></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Our board of directors has the authority to designate and issue preferred stock that may have
dividend, liquidation and other rights that are senior to those of our common stock. As of date of
this prospectus, 293,000 shares of our preferred stock have been issued and are outstanding.
Holders of our preferred stock are entitled to cumulative dividends before any dividends may be
declared or set aside on our common stock. Upon our voluntary or involuntary liquidation,
dissolution or winding up, before any payment is made to holders of our common stock,
holders of our preferred stock are entitled to receive an initial liquidation preference of
$1,000 per share, plus any accrued and unpaid dividends. This will reduce the remaining amount of
our assets, if any, available to distribute to holders of our common stock.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 8%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">
<DIV align="left">
<A name="104"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>USE OF PROCEEDS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">We will not receive any proceeds from sales of the shares of our common stock covered by this
prospectus by any of the selling stockholders. The proceeds from the sale of the common stock
covered by this prospectus are solely for the accounts of the selling stockholders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">We will bear all costs, expenses and fees in connection with the registration of the shares.
Brokerage commissions and similar selling expenses, if any, attributable to the offer or sale of
the shares will be borne by the selling stockholders.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 8%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>


<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left">
<A name="105"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>SELLING STOCKHOLDERS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">This prospectus relates to shares of our common stock previously issued pursuant to the Plans
to certain of our officers, directors and employees that are being registered for resale. All of
the shares of common stock that may be resold pursuant to this prospectus were previously acquired
by the selling stockholders upon the satisfaction of applicable vesting conditions relating to
certain equity awards (i.e., the re-listing of our common stock on the NASDAQ Global Market
and/or the passage of time).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">The selling stockholders may resell any or all of such shares of common stock at any time they
choose while this prospectus is effective. The inclusion in this prospectus of the officers,
directors and employees named below who have acquired shares of our common stock under the Plans
shall not be deemed to be an admission that any such individual is an &#147;affiliate&#148; of ours. There
is no assurance that any of the selling stockholders will sell any or all of the shares of common
stock covered by this prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Shares
of Common Stock Offered for Resale by Officers and Directors</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">
The following table sets forth the following information to the
extent known to the Company as
of July&nbsp;6, 2010 with respect to the shares of common stock previously issued under the Plans held
by each selling stockholder who is an officer or director of the Company:
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the name of such selling stockholder and the principal position or positions
with the Company held by such selling stockholder within the past three years;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the number and percentage of shares of our common stock such selling stockholder
beneficially owned as of July&nbsp;6, 2010;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the number of shares of our common stock to be offered for resale by such
selling stockholder in this offering; and</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the number and percentage of shares of our common stock to be beneficially owned
by such selling stockholder after completion of this offering.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">As used in following table, &#147;beneficial ownership&#148; is determined in accordance with Rule&nbsp;13d-3
under the Exchange Act and means the sole or shared power to vote or direct the voting or to
dispose or direct the disposition of any equity security. A person is deemed to be the beneficial
owner of securities that he has the right to acquire within 60&nbsp;days of July&nbsp;6, 2010 through the
exercise of any option, warrant or right.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">The address of each selling stockholder listed in the following table is c/o Verint Systems
Inc., 330 South Service Road, Melville, New York 11747.
</DIV>
<DIV align="center">
<TABLE style="font-size: 8pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="21%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6"><B>Shares of Common Stock</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Shares of</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6"><B>Shares of Common Stock</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6"><B>Beneficially Owned as of</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Common</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6"><B>Beneficially Owned After the</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6" style="border-bottom: 1px solid #000000"><B>July&nbsp;6,
2010 (1) (2)</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Stock to be</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6" style="border-bottom: 1px solid #000000"><B>Offering (1)(3)</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Name</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Position</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>

<TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Percentage (4)</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Sold</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>

<TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Percentage (4)</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD align="left" valign="top">Dan Bodner</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">President, Chief Executive Officer, Corporate Officer,
and Director</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">592,383</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.7</TD>
    <TD nowrap valign="top">%</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">227,074</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">365,309</TD>
    <TD nowrap valign="top">(5)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.0</TD>
    <TD nowrap valign="top">%</TD>
</TR>
<TR valign="bottom" style="padding-top: 0em">
    <TD align="left" valign="top">Victor A. DeMarines</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Director</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">34,000</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">*</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">17,000</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">17,000</TD>
    <TD nowrap valign="top">(6)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">*</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 0em; background: #cceeff">
    <TD align="left" valign="top">Peter Fante</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Chief Legal Officer, Chief
Compliance Officer,
Secretary, and
Corporate Officer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">128,029</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">*</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">76,794</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">51,235</TD>
    <TD nowrap valign="top">(7)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">*</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 0em">
    <TD align="left" valign="top">Kenneth A. Minihan</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Director</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">35,000</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">*</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">17,000</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">18,000</TD>
    <TD nowrap valign="top">(8)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">*</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 0em; background: #cceeff">
    <TD align="left" valign="top">Elan Moriah</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">President, Verint Witness Actionable
Solutions and
Verint Video Intelligence
Solutions and
Corporate Officer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">199,992</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">*</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">92,186</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">107,806</TD>
    <TD nowrap valign="top">(9)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">*</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 0em">
    <TD align="left" valign="top">Larry F. Myers</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Director</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23,000</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">*</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">17,000</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">6,000</TD>
    <TD nowrap valign="top">(10)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">*</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">
<DIV align="center">
<TABLE style="font-size: 8pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="21%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="28%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6"><B>Shares of Common Stock</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Shares of</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6"><B>Shares of Common Stock</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6"><B>Beneficially Owned as of</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Common</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6"><B>Beneficially Owned After the</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>

<TD nowrap align="center" colspan="6" style="border-bottom: 1px solid #000000"><B>July&nbsp;6, 2010 (1) (2)</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Stock to be</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6" style="border-bottom: 1px solid #000000"><B>Offering (1)(3)</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Name</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Position</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Percentage (4)</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Sold</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Percentage (4)</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD align="left" valign="top">David Parcell</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Managing Director, Europe, the Middle East, and Africa, and Corporate Officer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">111,701</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">*</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">63,561</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">48,140</TD>
    <TD nowrap valign="top">(11)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">*</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 0em">
    <TD align="left" valign="top">Douglas E. Robinson</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Chief Financial Officer and
Corporate Officer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">105,605</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">*</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">100,005</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">5,600</TD>
    <TD valign="top">(12)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">*</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 0em; background: #cceeff">
    <TD align="left" valign="top">Howard Safir</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">Director</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">40,000</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">*</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">17,000</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23,000</TD>
    <TD nowrap valign="top">(13)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">*</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 0em">
    <TD align="left" valign="top">Meir Sperling</TD>
    <TD>&nbsp;</TD>
    <TD><DIV style="margin-left:15px; text-indent:-15px">President, Verint Communications
Intelligence and
Investigative
Solutions and
Corporate Officer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">221,922</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">*</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">102,030</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">119,892</TD>
    <TD nowrap valign="top">(14)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">*</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>



<DIV align="left"><DIV style="font-size: 10pt; margin-top: 10pt; width: 18%; border-bottom: 1px solid #000000">&nbsp;</DIV></DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR style="font-size: 6pt">
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="96">&nbsp;</TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>Less than 1%.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(1)</TD>
    <TD>&nbsp;</TD>
    <TD>Unless otherwise indicated, includes shares beneficially owned by a spouse, minor children
and relatives sharing the same home, as well as entities owned or controlled by the named
person.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(2)</TD>
    <TD>&nbsp;</TD>
    <TD>The amounts appearing in this column
reflect the &#8220;Shares of Common Stock to be Sold&#8221; plus the &#8220;Shares
of Common Stock Beneficially Owned After the Offering.&#8221;</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(3)</TD>
    <TD>&nbsp;</TD>
    <TD>Assumes the selling stockholders sell all of the shares of our common stock covered by this
prospectus.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(4)</TD>
    <TD>&nbsp;</TD>
    <TD>Applicable percentage of ownership is based on 33,042,345 shares of our common stock issued
and outstanding as of June&nbsp;30, 2010 plus an additional
1,505,326 of the shares of our common
stock that may be offered pursuant to this prospectus that were acquired by the selling
stockholders on July&nbsp;2, 2010 and July&nbsp;6, 2010 or shares which have been previously acquired
upon vesting but have not yet been delivered, for a total of
34,547,671 shares. Because our
preferred stock is not currently convertible, the 10,072,966 shares of common stock that would
be issuable upon conversion of shares of our outstanding preferred stock (if converted on
June&nbsp;30, 2010) are not included in this number. Additionally, shares of our common stock subject to options, warrants, or rights which are currently exercisable or
exercisable within 60&nbsp;days are deemed outstanding for computing the ownership percentage of the person holding such
options, warrants, or rights, but are not deemed outstanding for computing the ownership percentage of any other
person.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(5)</TD>
    <TD>&nbsp;</TD>
    <TD>Includes options to purchase 261,835 shares of common stock
which are currently exercisable. Includes 103,474 shares of
restricted stock which are fully vested.
</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(6)</TD>
    <TD>&nbsp;</TD>
    <TD>Consists of options to purchase 17,000 shares of common stock that are currently exercisable.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(7)</TD>
    <TD>&nbsp;</TD>
    <TD>Includes options to purchase 45,000 shares of common stock
which are currently exercisable. Includes 6,235 shares of restricted
stock which are fully vested. </TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(8)</TD>
    <TD>&nbsp;</TD>
    <TD>Consists of options to purchase 18,000 shares of common stock that are currently exercisable.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(9)</TD>
    <TD>&nbsp;</TD>
    <TD>Includes options to purchase 91,088 shares of common stock
which are currently exercisable. Includes 16,718 shares of restricted
stock which are fully vested.
</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(10)</TD>
    <TD>&nbsp;</TD>
    <TD>Consists of options to purchase 6,000 shares of common stock that are currently exercisable.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(11)</TD>
    <TD>&nbsp;</TD>
    <TD>Includes options to purchase 41,196 shares of common stock
which are currently exercisable. Includes 6,944 shares of restricted
stock which are fully vested.
</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(12)</TD>
    <TD>&nbsp;</TD>
    <TD>Includes 5,600 restricted stock unit awards that will vest within 60 days of
July 6, 2010.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(13)</TD>
    <TD>&nbsp;</TD>
    <TD>Consists of options to purchase 23,000 shares of common stock that are currently exercisable.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(14)</TD>
    <TD>&nbsp;</TD>
    <TD>Includes options to purchase 99,892 shares of common stock
which are currently exercisable. Includes 20,000 shares of restricted
stock which are fully vested.
</TD>
</TR>

</TABLE>



<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->8<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Shares of Common Stock
Offered for Resale by Non-Officer Employees</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">The following is a list of all non-officer employees, regardless of number of shares held, who
previously acquired shares of our common stock in connection with the relisting of our common stock
on the NASDAQ Global Market on July&nbsp;6, 2010, pursuant to awards previously granted under the Plans.
These non-officer employees may sell up to an aggregate of 1,083,484 shares of common stock,
representing 3.1% of our issued and outstanding shares of common stock. This percentage of
ownership is based on 33,042,345 shares of our common stock issued and outstanding as of June&nbsp;30,
2010 plus an additional 1,505,326 of the shares of our common stock that may be offered pursuant to
this prospectus that were acquired by the selling stockholders on July&nbsp;2, 2010 and July&nbsp;6, 2010 or
shares which have been previously acquired upon vesting but have not yet been delivered, for a
total of 34,547,671 shares.
</DIV>


<P><DIV style="position: relative; float: left; width: 30%">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Emil Abramovich<BR>
Ran Achituv<BR>
Gil Adda<BR>
Mohit Aggrwal<BR>
Lynn Akers<BR>
Shay Akiva<BR>
Oscar A. Alban<BR>
Caroline Albert<BR>
Yuval Altman<BR>
Yaniv Amir<BR>
Yair Amsterdam<BR>
James Anderson<BR>
Zafrir Argov<BR>
Yoav Ariav<BR>
Eli Arman<BR>
Barbara Arndt<BR>
Sunil Aryan<BR>
Kar Ashutosh<BR>
Richard Philip Avenell<BR>
Amir Avrahami<BR>
Eyal Bachar<BR>
John William Bailey<BR>
Dror Bareket<BR>
Gustavo Baril<BR>
Robert John Barnes<BR>
Todd Barrick<BR>
Bryan Beach<BR>
Pedro Becquer<BR>
Gali Begas<BR>
Yanai Beilis<BR>
Natalie Bell<BR>
Stephen Bell<BR>
Merav Ben Rehav<BR>
Zwicka Ben Zion<BR>
Avishay Ben Zvi<BR>
Tami Ben-Jacob<BR>
Zalman Ben-Meir<BR>
Evyatar Ben-Shitrit<BR>
Asaf Ben-Zeev<BR>
David J. Bertolino<BR>
Shimon Bezalel<BR>
Michael Birdsong<BR>
Amit Bishoni<BR>
Dennis Blanco<BR>
Amy Blank<BR>
Scott Bluman<BR>
Cletus F. Bordeaux<BR>
Katherine Bost<BR>
Jean Boudreau<BR>
John R. Bourne<BR>
Craig Douglas Braisby<BR>
Richard Branchaud<BR>
Oren Bregman<BR>
Arie Briness<BR>
Josef Bronstein<BR>
Neri Brutzkus<BR>
Yossi Bulwik<BR>
Lawrence T. Butsch<BR>
William K. Byleveld<BR>
Marc Calahan<BR>
Joseph Carley

</DIV>
</DIV>
<DIV style="position: relative; float: left; margin-left: 2%; width: 30%">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Brian Carman<BR>
Saar Carmi<BR>
Dorit Carmon<BR>
Ido Carmon<BR>
Kenneth Carney<BR>
William Stuart Caton III<BR>
Yossi Chai<BR>
Andrew Ming Keung Chan<BR>
Eva Charissakis<BR>
Woon Ming Charles Cheng<BR>
Chong Va Cheong<BR>
Sophie Chetboun<BR>
Sharon Chouli<BR>
Anthony Cintado<BR>
Itzik Cohen<BR>
Nir Cohen<BR>
Tzachi Cohen<BR>
Yaniv Cohen<BR>
Donna Colby<BR>
Gail Cole<BR>
David C. Copeland<BR>
Sue Cordaro<BR>
John Crosby<BR>
Owen Crossweller<BR>
Patrick Dagenais<BR>
Ernest D&#146;Ambrose<BR>
Koby Danon<BR>
Shlomo Davidesco<BR>
Ran Davidovitz<BR>
Andrew Davies<BR>
Ajay Dawar<BR>
Frank Deans<BR>
Liberato Degruttola<BR>
Jose DeJesus<BR>
Kaushik Deka<BR>
Snehal Desai<BR>
Aude Desbrieres<BR>
Daniel Di Cicco<BR>
Michael DiBiase<BR>
Debra DiGianno<BR>
Marc Dittmer<BR>
Nancy DiVito<BR>
Thomas Dong<BR>
Boaz Dudovich<BR>
Gary Andrew Duke<BR>
John Christopher Duncan<BR>
Richard DuPree Jr.<BR>
William Durr<BR>
William L. Eckard III<BR>
Natalie Eckel<BR>
Charles Ehlers<BR>
Itzik Eidelman<BR>
Robert Eilbacher<BR>
Moshe Ekroni<BR>
Itai Elata<BR>
Amos Eliav<BR>
Miki Epstein<BR>
Ron Epstein<BR>
Benzi Falik<BR>
Jim Jianrong Fan<BR>
Richard Fietz

</DIV>
</DIV>
<DIV style="position: relative; float: right; width: 30%">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Boaz Fischer<BR>
Henrich Fischler<BR>
Karen Flynn<BR>
Stephen Foley<BR>
Paul Fournier<BR>
Michael Fox<BR>
Inbar Fridman<BR>
Michael Gagnon<BR>
Mike Gale<BR>
Ronen Galitzki<BR>
Zack Galon<BR>
Siddartha Gandhi<BR>
David Ganon<BR>
Joel Garnatz<BR>
Simon Gauthier<BR>
Smadar Gazit<BR>
Zoe Gee<BR>
Shimi Gil<BR>
Asaf Gilai<BR>
Darren Gill<BR>
Yossi Glass<BR>
Igor Goldberg<BR>
Royee Goldberg<BR>
Shay Gonen<BR>
Nicolas Gonthier<BR>
Kevin Graham Gower<BR>
Michael Graci<BR>
Ian Graham<BR>
Juliet P. Gram<BR>
Dov Granot<BR>
Moshe Granot<BR>
Marc Graveline<BR>
Richard Green<BR>
Galit Greenbaum<BR>
Kondal Gundla<BR>
Rajan Gupta<BR>
James Hagen<BR>
Eran Halfon<BR>
Eyal Halfon<BR>
Olaf Hansen<BR>
Andy Harper<BR>
Marcia J. Harris<BR>
Amy Conroy Hassinger<BR>
Andrew Robert Hawkes<BR>
Nati Hayun<BR>
Inon Hefetz<BR>
Kurt Allen Heier<BR>
Wallace Henderson<BR>
Nigel Christopher Hewett<BR>
Lior Hipsh<BR>
Tim Neil Holland<BR>
Ryan W. Hollenbeck<BR>
Andrew John Holmes<BR>
Itsik Horovitz<BR>
Gabriel Horowitz<BR>
Michael Howanitz<BR>
Jacqueline C. Hudson<BR>
Gary W. Humphrey<BR>
Susan Huston<BR>
Ofer Iankovitch<BR>
Rick V. Israel

</DIV>
</DIV>
<BR clear="all"><BR>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->9<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->

<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Philip Ives
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Thomas Lyerly
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Colin Maurice Pope</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Hugo Jacques
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Fiona Bridget Lynch
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ken Porter</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Guy Jacubovski
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tarun Mahajan
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sean Quigley</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Ron Jenik
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Genady Malinsky
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Avi Rabinovich</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Jay Jennings
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Zahi Malki
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Elad Rachamim</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Alexander Steven Johnson
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Michel J. Manche
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Marc Racicot</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Alush Joni
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Louis Marchand
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Fred Radley</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Jeff D. Jue
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Eran Marelly
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Gaurav Rastogi</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Steve Kaden
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Hugo Martel
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Serena Rayner</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Rafael Kaduri
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Roderick Matheson III
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Shay Razon</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Hitpreet Kang
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sheryl Mattison
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Alexander Reizis</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">David Kashak
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Mary Christine McAleer
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Shahar Remets</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Ronen Katav
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">John McCourt
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Lance Richardson</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Eyal Katz
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Todd McDermott
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">John Ringelman</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Ziv Katzir
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Nick Alexander McLean
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Carl David Robson</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Dana Katznelson
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Maureen E. McMahon
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Matthew Robson</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Nhevo Kaufman
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Yossi Medina
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Or Rochman</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Ron Keidar
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Nikola Meldrum
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Daniel Rock</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Persephone Keller
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Yuval Meron
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Alan J. Roden</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Shimon Keren
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Kevin Moore
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Nita Rodriguez</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Lior Kessel
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Gilad Mor
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Bryan Melvyn Rose</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Giles King
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">James Moretti
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Brigitte Routhier</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Yaron Klein
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Michel Morneau
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Shaul Rudnitsky</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Yaniv Knany
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Erez Nadav
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Kurt Rush</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Nicholas Kocaj
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Harish Nair
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Elizabeth Russell</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Jonathan Kohl
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Paul Najdzin
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Greg Ruzicka</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Willie Kouncar
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Joseph Neer
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">William Ryan</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Greg Krebs
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Nir Nehmad
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tom Sabga</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Kevin Kurimsky
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Yossi Nelkenbaum
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Bernard Sarel</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Adam Wan Fung Kwok
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Christopher Nelson
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">William D. Schneider</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Wai Chung Lam
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Orna Neuman
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ann Marie Schumann</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Charles Gregory Lampe
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Kasey Newman
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Craig Seebach</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Ronen Lampert
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Kimball Newman
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Noam Seelenfreund</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Arik Landau
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">James Nies
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ado Segal</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Robert Lander
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Roi Nobel
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ian Sephton</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Jim Langley Sr.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Roy Nugent
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Irit Shaaya-Segal</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Athena Larsen
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Efi Nuri
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Manishkumar Rameschandra Shah</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Erik Laurence
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Robert Nyberg
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Guy Shahmoon</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Marco Leclerc
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jane O&#146;Donnell
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Naama Shalom</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Chi Kin Lee
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Johnathan Oelsner
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Elad Sharon</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Tibor Leibovitch
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Yuval Ohana
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Omer Shavit</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Ilan Leizgold
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Christopher Orr
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Terry Sheehan</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Brian Leslie
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Yoni Osherov
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Karim Shehadeh</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Eli Lessel
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">William Pardue
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Eran Shehori</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Willy Chun Bong Leung
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Rob Parkinson
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ariel Shemesh</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Yan Lev
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Dhiren Patel
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Nick Shepherd</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Eli Levi
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Anne M Patton
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jim Sherring</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Shai Levi
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Norvel Patton
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Gregory Sherry</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">I. Craig Levin
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Paul Patton
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tal Shtauber</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Golan Levy
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Shefi Paz
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Shlomit Shteyer</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Shaked Levy
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Noam Pelles
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Wee Kiat Sim</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amanda Lewis
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jose Fortuna Penaredondo
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ziv Simhon</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Vincent Licciardi
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Nir Pery
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">David Singer</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Leslie Linsner
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Shlomo Pesach
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Eli Sinianski</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Shlomit Littig
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Niv Peskin
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Man Ho Sit</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Haim Litvak
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Krishna Pisipati
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Damian Smith</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Nataly Loewidt
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Marcel Poirier
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Robyn Smith</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->10<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->

<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Yehuda Sorek
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Gary S. Trudo
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Wayne Willis</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Barry Spielman
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Shiu Hang Kenneth Tsang
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jon Wilson</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Rodrigo Spinelli
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Stephanie Turner
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Rob Wint</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Daniel Spohrer
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Yossi Twizer
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Christopher Wood</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Kevin J. Steel
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Shiri Tzuk
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">David Worthley</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Oren Stern
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Thomas D. Ulreich
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Duane Sherrington Wright</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Andre St-Jean
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Yitzhak Vager
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Gur Yaari</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">David Stone
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Joseph P. Vidunas
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Gadi Yair</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Kevin Strange
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Daniel Vitlis
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Doron Yankovitch</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Bradley Stratton
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Brad Von Tersch
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Trent Yarbrough</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Edgar E. Suarez
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Joanne Voorhees
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Danny Yaron</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Dana Sugarman
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">John Voyatzis
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Aliaksei Yermakov</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">David Suttle
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Helen Vuletin
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Yossi Yitshaki</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Ram Swery
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Eran Wachman
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Koby Yosef</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Edward Syphers
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Mohammed Waseem
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Dganit Zahavi</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Nimrod Tabenkin
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Joseph Watson
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Christopher L. Zaske</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Shimi Tal
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Lori Weight
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ruthi Zimmerman</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Guy Tamir
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Dikla Weininger
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amir Zipori</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Erez Taoz
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Daniel Weiss
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Dror Daniel Ziv</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Cheryle Tapp
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Miki Weiss
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Yoel Zmuckas</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Ryan Tate
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Zvi Weiss
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Yoram Zohar</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Nitzan Tau
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Peter Weller
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Eytan Zucker</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Matthew Paul Tengwall
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Steve Weller
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Alexander Zur</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Simon Thewes
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Daniel Wensel
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Dror Zur</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Guy Toibin
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Wynne Wilder
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ido Zur</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Nancy Y. Treaster
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Timothy Wilkie</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Vladimir Trostyanetski
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jamie Williams</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->11<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">
<DIV align="left">
<A name="106"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>PLAN OF DISTRIBUTION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">The selling stockholders have not advised us of any specific plan for the sale or distribution
of the shares of common stock covered by this prospectus. If and when they occur, such sales may be
made in any of the following manners:
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>On the NASDAQ Global Market (or through the facilities of any national
securities exchange or U.S. inter-dealer quotation system of a registered national
securities association on which shares of our common stock are then listed,
admitted to unlisted trading privileges or included for quotation);</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>in public or privately negotiated transactions;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>in transactions involving principals or brokers;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>in a combination of such methods of sale; or</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="12%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>any other lawful methods.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Although sales of the shares of common stock covered by this prospectus are, in general,
expected to be made at market prices prevailing at the time of sale, the shares may also be sold at
prices related to such prevailing market prices or at negotiated prices, which may differ
considerably.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">When offering the shares of common stock covered by this prospectus, each of the selling
stockholders and any broker-dealers who sell the shares for the selling stockholders may be
&#147;underwriters&#148; within the meaning of the Securities Act, and any profits realized by such selling
stockholders and the compensation of such broker-dealers may be underwriting discounts and
commissions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Sales through brokers may be made by any method of trading authorized by any stock exchange or
market on which our common stock may be listed, including block trading in negotiated transactions.
Without limiting the foregoing, such brokers may act as dealers by purchasing any or all of the
shares of common stock covered by this prospectus, either as agents for others or as principals for
their own accounts, and reselling such shares pursuant to this prospectus. The selling stockholders
may effect such transactions directly, or indirectly through underwriters, broker-dealers or agents
acting on their behalf. In connection with such sales, such broker-dealers or agents may receive
compensation in the form of commissions, concessions, allowances or discounts, any or all of which
might be in excess of customary amounts.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Each of the selling stockholders is acting independently of us in making decisions with
respect to the timing, manner and size of each sale of shares. We have not been advised of any
definitive selling arrangement at the date of this prospectus between any selling stockholder and
any broker-dealer or agent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">To the extent required, the names of any agents, broker-dealers or underwriters and applicable
commissions, concessions, allowances or discounts, and any other required information with respect
to any particular offer of the shares by the selling stockholders, will be set forth in a
prospectus supplement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">The expenses of preparing and filing this prospectus and the related registration statement
with the SEC will be paid entirely by us. The selling stockholders have been advised that they are
subject to the applicable provisions of the Exchange Act, including without limitation Rule&nbsp;10b-5
thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Neither we nor the selling stockholders can currently estimate the amount of commissions or
discounts, if any, that will be paid by the selling stockholders on account of their sales of the
shares from time to time.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->12<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">
<DIV align="left">
<A name="107"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>LEGAL MATTERS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">The validity of the issuance of the shares of common stock offered in this prospectus will be
passed upon for us by Jones Day, New York, New York.
</DIV>
<DIV align="left">
<A name="108"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>EXPERTS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">The
consolidated financial statements, incorporated in this prospectus by reference from Verint Systems Inc.&#146;s Annual
Report on Form 10-K for the year ended January&nbsp;31, 2010, and the
effectiveness of Verint Systems Inc.&#146;s internal control
over financial reporting have been audited by Deloitte &#038; Touche LLP, an independent registered public accounting firm,
as stated in their reports, which are incorporated herein by reference (which reports (1)&nbsp;express an unqualified
opinion on the consolidated financial statements and include an explanatory paragraph relating to the adoption of new
accounting guidance for the reporting and disclosure of noncontrolling interests, and (2)&nbsp;express an adverse opinion on
the effectiveness of Verint Systems Inc.&#146;s internal control over financial reporting because of material weaknesses).
Such consolidated financial statements have been so incorporated in reliance upon the reports of such firm given upon
their authority as experts in accounting and auditing.
</DIV>
<DIV align="left">
<A name="109"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>INFORMATION INCORPORATED BY REFERENCE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">The SEC allows us to incorporate by reference certain of our publicly filed documents into
this prospectus, which means that we can disclose important business and financial information to
you that is not included in or delivered with this prospectus by referring you to publicly filed
documents that contain the omitted information. The information incorporated by reference is
considered to be part of this prospectus, and any later information that we file with the SEC will
automatically update and supersede this information. You will be deemed to have notice of all
information incorporated by reference into this prospectus as if that information were included in
this prospectus.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 8%">The following documents that we have filed with the SEC are incorporated herein by reference:
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>our Annual Report on Form 10-K for the year ended January&nbsp;31, 2010, filed
with the SEC on May&nbsp;19, 2010;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>our Quarterly Report on Form 10-Q for the quarterly period ended April&nbsp;30, 2010,
filed with the SEC on June&nbsp;9, 2010;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>our Current Reports on Form 8-K, filed with the SEC on
February&nbsp;4, 2010, February&nbsp;23, 2010, March&nbsp;3, 2010, March&nbsp;22,
2010, April&nbsp;21, 2010 and May&nbsp;3, 2010; and</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the description of our common stock, par value $0.001, per share, contained in our
Registration Statement on Form 8-A, filed with the SEC on July&nbsp;2, 2010.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Except as otherwise indicated, all documents we file with the SEC pursuant to Sections&nbsp;13(a),
13(c), 14 and 15(d) of the Exchange Act subsequent to the date of this prospectus and prior to the
filing of a post-effective amendment that indicates that all securities offered have been sold or
that deregisters all securities then remaining unsold will be deemed to be incorporated by
reference into this prospectus and to be part hereof from the date of filing of such documents.
Any statement contained in any document incorporated or deemed to be incorporated by reference
herein will be deemed to be modified or superseded for purposes of this prospectus to the extent
that a statement contained herein or in any other subsequently filed document which also is or is
deemed to be incorporated by reference herein modifies or supersedes such statement. Any such
statement so modified or superseded will not be deemed, except as modified or superseded, to
constitute a part of this prospectus. This prospectus is part of a Registration Statement on Form
S-8 that we filed with the SEC and does not contain all of the information set forth in that
Registration Statement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">We will provide, free of charge, to any person to whom a copy of this prospectus is delivered,
upon written or oral request, a copy of any or all of the documents incorporated by reference into
this prospectus, other than exhibits to those documents unless specifically incorporated by
reference. To request a copy of those documents, you should contact us at the address set forth
below under &#147;Where You Can Find Additional Information.&#148;
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->13<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">
<DIV align="left">
<A name="110"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>WHERE YOU CAN FIND ADDITIONAL INFORMATION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">We file annual, quarterly and current reports, proxy statements and other information with the
SEC. The SEC allows us to incorporate by reference the information we file with them, which means
that we can disclose important business and financial information to you that is not included in or
delivered with this prospectus by referring you to publicly filed documents that contain the
omitted information. We provide a list of all documents we incorporate by reference into this
prospectus under &#147;Information Incorporated by Reference&#148; above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Through our website at www.verint.com, we make available the information that we incorporate
by reference into this prospectus, as well as other reports, proxy statements and other information
that we file with the SEC. You may also read and copy those materials at the SEC&#146;s Public
Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at (800)&nbsp;SEC-0330
for further information on the operation of the Public Reference Room. In addition, we are required
to file electronic versions of those materials with the SEC through the SEC&#146;s EDGAR system. The SEC
maintains a website at www.sec.gov that contains reports, proxy statements and other information
that registrants, such as we, file electronically with the SEC. Our website address set forth
above is not intended to be an active link, and information on our website is not incorporated in,
and should not be construed to be a part of, this prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Each person to whom a prospectus is delivered may also request a copy of those materials, free
of charge, by contacting us at the following address:
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt">Verint Systems Inc.<BR>
330 South Service Road<BR>
Melville, New York 11747<BR>
(631)&nbsp;962-9600<BR>
Attn: Corporate Secretary
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->14<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>PART II</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;3. Incorporation of Documents by Reference.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">The following documents filed by the Company with the Commission are incorporated herein by
reference:
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the Company&#146;s Annual Report on Form 10-K for the year ended January&nbsp;31, 2010,
filed with the Commission on May&nbsp;19, 2010;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the Company&#146;s Quarterly Report on Form 10-Q for the quarterly period ended April&nbsp;30,
2010, filed with the Commission on June&nbsp;9, 2010;</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the Company&#146;s Current Reports on Form 8-K, filed with
the Commission on February&nbsp;4, 2010, February&nbsp;23, 2010,
March&nbsp;3, 2010, March&nbsp;22, 2010, April&nbsp;21, 2010 and May&nbsp;3, 2010; and</TD>
</TR>

</TABLE>
</DIV>

<DIV style="margin-top: 10pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="8%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>the description of the Company&#146;s common stock, par value $0.001, per share,
contained in the Registrant&#146;s Registration Statement on Form 8-A, filed with the
Commission on July&nbsp;2, 2010.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">All documents filed by the Company with the Commission pursuant to Sections&nbsp;13(a), 13(c), 14
and 15(d) of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), subsequent to
the date of this Registration Statement and prior to the filing of a post-effective amendment that
indicates that all securities offered have been sold or which deregisters all securities then
remaining unsold will be deemed to be incorporated by reference in this Registration Statement and
to be part hereof from the date of filing of such documents. Any statement contained in any
document incorporated or deemed to be incorporated by reference herein will be deemed to be
modified or superseded for purposes of this Registration Statement to the extent that a statement
contained herein or in any other subsequently filed document which also is or is deemed to be
incorporated by reference herein modifies or supersedes such statement. Any such statement so
modified or superseded will not be deemed, except as modified or superseded, to constitute a part
of this Registration Statement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;4. Description of Securities.</B>
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 8%">Not applicable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;5. Interests of Named Experts and Counsel.</B>
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 8%">Not applicable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;6. Indemnification of Directors and Officers.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Section&nbsp;102 of the Delaware General Corporation Law (the &#147;DGCL&#148;) allows a corporation to
eliminate the personal liability of directors of a corporation to the corporation or its
stockholders for monetary damages for breach of fiduciary duty as a director, except where the
director breached the duty of loyalty, failed to act in good faith, engaged in intentional
misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock
repurchase in violation of the DGCL or obtained an improper personal benefit.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Section&nbsp;145 of the DGCL provides, among other things, that the Company may indemnify any
person who was or is a party or is threatened to be made a party to any threatened, pending or
completed action, suit or proceeding other than an action by or in the right of the Company, by
reason of the fact that the person is or was a director, officer, agent or employee of the Company,
or is or was serving at the Company&#146;s request as a director, officer, agent or employee of another
corporation, partnership, joint venture, trust or other enterprise, against expenses, including
attorneys&#146; fees, judgments, fines and amounts paid in settlement actually and reasonably incurred
by the person in connection with such action, suit or proceeding, if such person acting in good
faith and in a manner he or she reasonably believed to be in the best interest, or not opposed to
the best interest, of the Company, and with respect to any criminal action or proceeding had no
reasonable cause to believe his or her conduct was unlawful. The power to indemnify applies to
actions brought by or in the right of the Company as well, but only to the extent of defense
expenses, including attorneys&#146; fees, actually and reasonably incurred in connection with the
defense or settlement of such action or suit, and with the further limitation that in such actions
no indemnification shall be made in respect of any claim, issue or matter as to which any person
shall have been adjudged liable to the Company, unless the court believes that in light of all the
circumstances indemnification should apply. Furthermore, under the DGCL, if such person is
successful on the merits or otherwise in the defense of any action referred to above, or in the
defense of any claim, issue or matter therein, such person shall be indemnified against expenses
(including attorneys&#146; fees) actually and reasonably incurred by such person in connection
therewith.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->II-1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Section&nbsp;174 of the DGCL provides, among other things, that a director, who willfully or
negligently approves of an unlawful payment of dividends or an unlawful purchase or redemption of
stock, may be held liable for such actions. A director who was either absent when the unlawful
actions were approved or dissented at the time, may avoid liability by causing his or her dissent
to such actions to be entered in the books containing minutes of the meetings of the board of
directors at the time such action occurred or immediately after such absent director receives
notice of the unlawful acts.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">The above is a general summary of certain indemnity provisions of the DGCL and is subject, in
all cases, to the specific and detailed provisions of the Sections referenced herein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">As permitted by the DGCL, our certificate of incorporation includes a provision to eliminate
the personal liability of our directors for monetary damages for breach or alleged breach of their
fiduciary duties as directors, subject to limited exceptions. Our certificate of incorporation also
provides that every person who is or was our director, officer, employee or agent or is or was a
director, officer, employee or agent of any other enterprise, serving as such at our request, shall
be indemnified to the fullest extent permitted by law for all expenses and liabilities actually and
reasonably incurred in connection with any proceeding involving such person in this capacity. The
Company has also entered into an indemnification agreement with each of its directors and officers under
which the Company agreed to provide indemnification and expense reimbursement as outlined above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">The Company has agreed to indemnify Comverse Technology, Inc. (&#147;Comverse&#148;) and its directors,
officers, employees and agents against any liabilities arising out of any claim that any provision
of the business opportunities agreement, entered into by the Company and Comverse, breaches any
duty that may be owed to the Company by Comverse or any such person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">The Company has provided directors&#146; and officers&#146; liability insurance coverage for the
Company&#146;s officers and directors since 2006. Previously, Comverse obtained directors&#146; and
officers&#146; liability insurance which also provided coverage for the Company&#146;s officers and directors
under a Corporate Services Agreement entered into by the Company and Comverse.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Each of the Company&#146;s directors who is also a director and/or officer of Comverse has an
indemnification agreement with Comverse. Under this agreement Comverse has agreed to indemnify
such person against losses and expenses, to the extent permitted by law, incurred by such person in
connection with his service as director and/or officer of Comverse or any of its subsidiaries,
including the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;7. Exemption from Registration Claimed.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">As previously disclosed, as a result of the Company&#146;s inability to file required reports with
the Commission during the Company&#146;s extended filing delay
period, the Company previously ceased using its
existing registration statements on Form S-8 to make equity grants to employees. On May&nbsp;24, 2007,
the Company received a no-action letter from the Commission upon which the Company relied to make
broad-based equity grants to employees under a no-sale theory. The Company has also made equity
grants to directors, executive officers and certain other non-officer executives who qualify as
accredited investors in reliance upon the exemption from registration provided by Regulation&nbsp;D of
the Securities Act of 1933. All of the shares of common stock that may be offered pursuant to this
registration statement were acquired by the selling stockholders upon the
grant of restricted stock pursuant to an applicable private placement exemption or the
vesting of equity awards
issued pursuant to the no-sale theory or an applicable private placement exemption.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->II-2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;8. Exhibits.</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="67%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="21%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Filed Herewith /</B></TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Incorporated by Reference</B></TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Description</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>from</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amended and Restated Certificate of Incorporation of Verint
Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;S-1 (Commission
File No.&nbsp;333-82300)
effective on May&nbsp;16,
2002</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Certificate of Designation, Preferences and Rights of the Series&nbsp;A
Convertible Perpetual Preferred Stock
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;8-K filed on May
30, 2007 8-K</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.3</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amended and Restated By-laws of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March&nbsp;17, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.4</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Specimen Common Stock certificate
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;S-1 (Commission
File No.&nbsp;333-82300)
effective on May&nbsp;16,
2002</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.5</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Specimen Series&nbsp;A Convertible Perpetual Preferred Stock certificate
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March&nbsp;17, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.6</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Verint Systems Inc. Stock Incentive Compensation Plan (as amended
through December&nbsp;12, 2002)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on May
1, 2003</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.7</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;1 to Verint Systems Inc. Stock Incentive
Compensation Plan (dated December&nbsp;23, 2008)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March&nbsp;17, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.8</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;2 to Verint Systems Inc. Stock Incentive
Compensation Plan (dated March&nbsp;4, 2009)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March&nbsp;17, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.9</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Verint Systems Inc. 2004 Stock Incentive Compensation Plan, as
amended and restated
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;8-K filed on
January&nbsp;10, 2006</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.10</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;1 to Verint Systems Inc. 2004 Stock Incentive
Compensation Plan, as amended and restated (dated December&nbsp;23,
2008)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March&nbsp;17, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.11</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Witness Systems Amended and Restated Stock Incentive Plan
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Witness Systems, Inc.
Form&nbsp;10-Q filed on
August&nbsp;9, 2005</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.12</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;1 to Witness Systems Amended and Restated Stock
Incentive Plan (dated May&nbsp;29, 2001)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Witness Systems, Inc.
Form&nbsp;10-K filed on March&nbsp;17, 2006</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.13</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;2 to Witness Systems Amended and Restated Stock
Incentive Plan (dated January&nbsp;15, 2004)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Witness Systems, Inc.
Form&nbsp;10-K filed on March&nbsp;15, 2004</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.14</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;3 to Witness Systems Amended and Restated Stock
Incentive Plan (dated December&nbsp;6, 2007)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March&nbsp;17, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.15</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;4 to Witness Systems Amended and Restated Stock
Incentive Plan (dated December&nbsp;23, 2008)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March&nbsp;17, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">5.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Opinion of Jones Day
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed Herewith</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Consent of Deloitte &#038; Touche LLP
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed Herewith</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Consent of Jones Day (included in Exhibit&nbsp;5.1)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed Herewith</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->II-3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;9. Undertakings.</B>
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 8%">(a)&nbsp;The undersigned Registrant hereby undertakes:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 12%">(1)&nbsp;To file, during any period in which offers or sales are being made, a post-effective
amendment to this registration statement:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 8%; text-indent: 8%">(i)&nbsp;to include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 8%; text-indent: 8%">(ii)&nbsp;to reflect in the prospectus any facts or events arising after the effective date
of this registration statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the information set
forth in this registration statement; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 8%; text-indent: 8%">(iii)&nbsp;to include any material information with respect to the plan of distribution not
previously disclosed in this registration statement or any material change to such
information in this registration statement;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 12%"><I>provided, however</I>, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the registration
statement is on Form S-8, and the information required to be included in a post-effective amendment
by those paragraphs is contained in reports filed with or furnished to the Commission by the
Registrant pursuant to Section&nbsp;13 or Section 15(d) of the Exchange Act that are incorporated by
reference in this registration statement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 12%">(2)&nbsp;That, for the purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time will be deemed to be
the initial <I>bona fide </I>offering thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 12%">(3)&nbsp;To remove from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">(b)&nbsp;The undersigned Registrant hereby undertakes that, for purposes of determining any
liability under the Securities Act, each filing of the Registrant&#146;s annual report pursuant to
Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an
employee benefit plan&#146;s annual report pursuant to Section 15(d) of the Exchange Act) that is
incorporated by reference in this registration statement will be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that
time will be deemed to be the initial <I>bona fide </I>offering thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">(c)&nbsp;Insofar as indemnification for liabilities arising under the Securities Act may be
permitted to directors, officers and controlling persons of the Registrant pursuant to the
foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the
Commission such indemnification is against public policy as expressed in the Securities Act and is,
therefore, unenforceable. In the event that a claim for indemnification against such liabilities
(other than the payment by the Registrant of expenses incurred or paid by a director, officer or
controlling person of the Registrant in the successful defense of any action, suit or proceeding)
is asserted by such director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter has been settled
by controlling precedent, submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Securities Act and will be
governed by the final adjudication of such issue.
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->II-4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">
<DIV align="left">
<A name="111"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>SIGNATURES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it
has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
has duly caused this Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the city of Melville, State of New York, on this 6th day of July,
2010.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">VERINT SYSTEMS INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Dan Bodner
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Dan Bodner&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">President and Chief Executive Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
</TABLE>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 8%">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has
been signed by the following persons in the capacities and on the dates indicated.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="70%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Dan Bodner
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Dan Bodner, Chief Executive Officer
and President; Director of Verint Systems Inc.<br>
(Principal Executive Officer)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">July&nbsp;6, 2010&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Douglas E. Robinson
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Douglas E. Robinson, Chief Financial Officer
of Verint Systems Inc.<br>
(Principal Financial Officer and Principal Accounting Officer)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">July&nbsp;6, 2010&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Paul D. Baker
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Paul D. Baker, Director of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">July&nbsp;6, 2010&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ John Bunyan
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
John Bunyan, Director of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">July&nbsp;6, 2010&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Andre Dahan
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Andre Dahan, Chairman of the Board of Directors of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">July&nbsp;6, 2010&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Victor A. DeMarines
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Victor A. DeMarines, Director of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">July&nbsp;6, 2010&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Kenneth A. Minihan
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Kenneth A. Minihan, Director of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">July&nbsp;6, 2010&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->II-5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="70%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="25%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Larry Myers
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Larry Myers, Director of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">July&nbsp;6, 2010&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Howard Safir
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Howard Safir, Director of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">July&nbsp;6, 2010&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Shefali Shah
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Shefali Shah, Director of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">July&nbsp;6, 2010&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Stephen M. Swad
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Stephen M. Swad, Director of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">July&nbsp;6, 2010&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Lauren Wright
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Lauren Wright, Director of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">July&nbsp;6, 2010&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->II-6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">
<DIV align="left">
<A name="112"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>EXHIBIT INDEX</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="67%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="21%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Filed Herewith /</B></TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center"><B>Incorporated by Reference</B></TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Description</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>from</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amended and Restated Certificate of Incorporation of Verint
Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;S-1 (Commission
File No.&nbsp;333-82300)
effective on May&nbsp;16,
2002</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Certificate of Designation, Preferences and Rights of the Series&nbsp;A
Convertible Perpetual Preferred Stock
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;8-K filed on May
30, 2007 8-K</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.3</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amended and Restated By-laws of Verint Systems Inc.
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March&nbsp;17, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.4</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Specimen Common Stock certificate
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;S-1 (Commission
File No.&nbsp;333-82300)
effective on May&nbsp;16,
2002</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.5</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Specimen Series&nbsp;A Convertible Perpetual Preferred Stock certificate
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March&nbsp;17, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.6</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Verint Systems Inc. Stock Incentive Compensation Plan (as amended
through December&nbsp;12, 2002)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on May
1, 2003</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.7</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;1 to Verint Systems Inc. Stock Incentive
Compensation Plan (dated December&nbsp;23, 2008)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March&nbsp;17, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.8</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;2 to Verint Systems Inc. Stock Incentive
Compensation Plan (dated March&nbsp;4, 2009)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March&nbsp;17, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.9</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Verint Systems Inc. 2004 Stock Incentive Compensation Plan, as
amended and restated
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;8-K filed on
January&nbsp;10, 2006</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.10</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;1 to Verint Systems Inc. 2004 Stock Incentive
Compensation Plan, as amended and restated (dated December&nbsp;23,
2008)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March&nbsp;17, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.11</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Witness Systems Amended and Restated Stock Incentive Plan
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Witness Systems, Inc.
Form&nbsp;10-Q filed on
August&nbsp;9, 2005</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.12</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;1 to Witness Systems Amended and Restated Stock
Incentive Plan (dated May&nbsp;29, 2001)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Witness Systems, Inc.
Form&nbsp;10-K filed on March&nbsp;17, 2006</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.13</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;2 to Witness Systems Amended and Restated Stock
Incentive Plan (dated January&nbsp;15, 2004)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Witness Systems, Inc.
Form&nbsp;10-K filed on March&nbsp;15, 2004</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.14</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;3 to Witness Systems Amended and Restated Stock
Incentive Plan (dated December&nbsp;6, 2007)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March&nbsp;17, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4.15</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Amendment No.&nbsp;4 to Witness Systems Amended and Restated Stock
Incentive Plan (dated December&nbsp;23, 2008)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form&nbsp;10-K filed on March&nbsp;17, 2010</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">5.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Opinion of Jones Day
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed Herewith</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23.1</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Consent of Deloitte &#038; Touche LLP
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed Herewith</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23.2</TD>
    <TD nowrap valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Consent of Jones Day (included in Exhibit&nbsp;5.1)
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filed Herewith</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->II-7<!-- /Folio -->
</DIV>

</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "c03128sv8.htm", "description": "FORM S-8", "secsgml_size_bytes": 204603}]
{"company-data": {"conformed-name": "VERINT SYSTEMS INC", "cik": "0001166388", "assigned-sic": "7373", "irs-number": "113200514", "state-of-incorporation": "DE", "fiscal-year-end": "0131"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-168000", "film-number": "10940816"}, "business-address": {"street1": "330 SOUTH SERVICE ROAD", "city": "MELVILLE", "state": "NY", "zip": "11747", "phone": "6319629600"}, "mail-address": {"street1": "330 SOUTH SERVICE ROAD", "city": "MELVILLE", "state": "NY", "zip": "11747"}}
Form S-8
Table of Contents
As
filed with the Securities and Exchange Commission on July 7, 2010
Registration No. 333-________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
VERINT SYSTEMS INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation or organization)
11-3200514
(I.R.S. Employer Identification No.)
330 South Service Road, Melville, New York
(Address of Principal Executive Offices)
11747
(Zip Code)
VERINT SYSTEMS INC. STOCK INCENTIVE COMPENSATION PLAN
VERINT SYSTEMS INC. 2004 STOCK INCENTIVE COMPENSATION PLAN
WITNESS SYSTEMS, INC. AMENDED AND RESTATED STOCK INCENTIVE PLAN
(Full title of the plan)
Peter Fante
Chief Legal Officer
Verint Systems Inc.
330 South Service Road
Melville, New York 11747
(Name and address of agent for service)
(631) 962-9600
(Telephone number, including area code, of agent for service)
With copies to:
Randi C. Lesnick, Esq.
Jones Day
222 East 41
st
Street
New York, New York 10017
(212) 326-3939
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated
filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
(Check one):
Large accelerated filer
o
Accelerated filer
þ
Non-accelerated filer
o
Smaller reporting company
o
(Do not check if a smaller reporting company)
CALCULATION OF REGISTRATION FEE
Proposed Maximum
Proposed Maximum
Title of Securities to be
Amount to be
Offering Price Per
Aggregate Offering
Amount of
Registered
Registered
(1)(2)
Share
(3)
Price
(3)
Registration Fee
Common Stock, $0.001 par
value per share
1,813,134
$23.15
$41,974,052.10
$2,992.75
(1)
Pursuant to Rule 416 under the Securities Act of 1933 (the "Securities Act"), this
Registration Statement shall include any additional shares of common stock, par value $0.001
per share (the "Common Stock"), that may become issuable as a result of stock splits, stock
dividends or similar transactions.
(2)
Represents 157,086 shares of Common Stock previously issued pursuant to the Verint Systems
Inc. Stock Incentive Compensation Plan, as amended to be registered for resale; 1,250,024 shares
of Common Stock previously issued pursuant to the Verint Systems Inc. 2004 Stock
Incentive Compensation Plan, as amended, to be registered for resale; and 406,024 shares of
Common Stock previously issued pursuant to the Witness Systems, Inc. Amended and Restated
Stock Incentive Plan, as amended, to be registered for resale. The Common Stock has been
previously issued to officers, directors or employees.
(3)
Estimated solely for the purpose of calculating the amount of the registration fee pursuant
to Rule 457(c) under the Securities Act, based on the average of the high and low prices of
our Common Stock as reported by the NASDAQ Global Market on July 6, 2010.
Table of Contents
EXPLANATORY NOTE
This Registration Statement contains two parts. The first part contains a resale prospectus
prepared in accordance with the requirements of General Instruction C to Form S-8 that covers
resales of "restricted securities" and "control securities" (in each case, as defined in General
Instruction C to Form S-8). This resale prospectus relates to shares of common stock, $0.001 par
value per share, of Verint Systems Inc. (the "Company") previously issued to certain officers,
directors and employees of the Company pursuant to the Verint Systems Inc. Stock Incentive
Compensation Plan, as amended; the Verint Systems Inc. 2004 Stock Incentive Compensation Plan, as
amended; and the Witness Systems, Inc. Amended and Restated Stock Incentive Plan. The second part
of this Registration Statement contains Information Required in the Registration Statement pursuant
to Part II of Form S-8.
Table of Contents
REOFFER PROSPECTUS
VERINT SYSTEMS INC.
1,813,134 SHARES OF COMMON STOCK
This prospectus relates to the resale, from time to time, of up to 1,813,134 shares of our
common stock, $0.001 par value per share, by the selling stockholders listed in this prospectus.
The selling stockholders acquired such shares pursuant to grants made under (1) the Verint Systems
Inc. Stock Incentive Compensation Plan, as amended; (2) the Verint Systems Inc. 2004 Stock
Incentive Compensation Plan, as amended; or (3) the Witness Systems, Inc. Amended and Restated
Stock Incentive Plan, as amended. The Verint Systems Inc. Stock Incentive Compensation Plan, as
amended; the Verint Systems Inc. 2004 Stock Incentive Compensation Plan, as amended; and the
Witness Systems, Inc. Amended and Restated Stock Incentive Plan, as amended, are collectively
referred to in this prospectus as the "Plans."
We will not receive any proceeds from sales of the shares of our common stock covered by this
prospectus by any of the selling stockholders. The shares may be offered, from time to time, by
any or all of the selling stockholders through ordinary brokerage transactions, in negotiated
transactions or in other transactions, at such prices as he, she or they may determine, which may
relate to market prices prevailing at the time of sale or be a negotiated price. See "Plan of
Distribution." We will bear all costs, expenses and fees in connection with the registration of
the shares. Brokerage commissions and similar selling expenses, if any, attributable to the offer
or sale of the shares will be borne by the selling stockholders.
Each selling stockholder and any broker executing selling orders on behalf of a selling
stockholder may be deemed to be an "underwriter" as defined in the Securities Act of 1933, as
amended, or the Securities Act. If any broker-dealers are used to effect sales, any commissions
paid to broker-dealers and, if broker-dealers purchase any of the shares of common stock covered by
this prospectus as principals, any profits received by such broker-dealers on the resales of shares
may be deemed to be underwriting discounts or commissions under the Securities Act. In addition,
any profits realized by the selling stockholders may be deemed to be underwriting commissions.
Shares of our common stock are listed on the NASDAQ Global Market under the symbol "VRNT." On
July 6, 2010, the last reported sale price of our common stock
was $23.80 per share.
Investing in shares of our common stock involves a high degree of risk. See "Risk Factors" on
page 4 of this prospectus and the other risk factors set forth in our periodic and other filings
with the Securities and Exchange Commission, or the SEC, including those set forth in our Annual
Report on Form 10-K for the year ended January 31, 2010, for a discussion of certain factors
that should carefully be considered by prospective purchasers.
Neither the SEC nor any state securities commission has approved or disapproved of these
securities or determined if this prospectus is truthful or complete. Any representation to the
contrary is a criminal offense.
This
prospectus is dated July 7, 2010.
TABLE OF CONTENTS
Page
Prospectus Summary
1
Cautionary Note on Forward-Looking Statements
2
Risk Factors
4
Use of Proceeds
6
Selling Stockholders
7
Plan of Distribution
12
Legal Matters
13
Experts
13
Information Incorporated by Reference
13
Where You Can Find Additional Information
14
Exhibit 5.1
Exhibit 23.1
You should rely only on the information contained in or incorporated by reference into this
prospectus. We have not authorized any other person to provide you with additional information or
information different from that contained in or incorporated by reference into this prospectus.
The selling stockholders may, from time to time, offer to sell shares of our common stock only in
jurisdictions where the offer or sale is permitted. You should not assume that the information
contained in this prospectus is accurate as of any date other than the date on the front cover of
this prospectus or that the information contained in any document incorporated by reference into
this prospectus is accurate as of any date other than the date of the document incorporated by
reference.
i
Table of Contents
PROSPECTUS SUMMARY
This summary highlights information contained elsewhere in or incorporated by reference into
this prospectus. This summary is not complete and does not contain all of the information that may
be important to you and that you should consider before investing in shares of our common stock.
You should carefully read the entire prospectus, including the section titled "Risk Factors," and
the other information incorporated by reference into this prospectus before making an investment
decision.
References in this prospectus to the terms "Verint," "the Company," "we," "us" and "our," or
other similar terms, mean Verint Systems Inc., together with its consolidated subsidiaries, unless
the context indicates otherwise.
VERINT SYSTEMS INC.
We are a global leader in Actionable Intelligence
®
solutions and value-added services. Our
solutions enable organizations of all sizes to make timely and effective decisions to improve
enterprise performance and make the world a safer place. More than 10,000 organizations in over 150
countries—including over 80% of the Fortune 100—use Verint solutions to capture, distill and
analyze complex and underused information sources, such as voice, video and unstructured text.
In the enterprise market, our workforce optimization solutions help organizations enhance
customer service operations in contact centers, branches and back-office environments to increase
customer satisfaction, reduce operating costs, identify revenue opportunities and improve
profitability. In the security intelligence market, our video intelligence, public safety and
communications intelligence solutions are vital to government and commercial organizations in their
efforts to protect people and property and neutralize terrorism and crime.
Headquartered in Melville, New York, we support our customers around the globe directly and
with an extensive network of selling and support partners. Our principal executive offices are
located at 330 South Service Road, Melville, New York 11747, our telephone number is (631) 962-9600
and our website address is www.verint.com. Information contained on our website is not a part of
this prospectus.
1
Table of Contents
CAUTIONARY NOTE ON FORWARD-LOOKING STATEMENTS
Certain statements discussed in this prospectus constitute "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of 1995, the provisions of Section 27A
of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, or the
Exchange Act (which Sections were adopted as part of the Private Securities Litigation Reform Act
of 1995). Forward-looking statements include financial projections, statements of plans and
objectives for future operations, statements of future economic performance and statements of
assumptions relating thereto. Forward-looking statements are often identified by future or
conditional words such as "will," "plans," "expects," "intends," "believes," "seeks," "estimates"
or "anticipates," by variations of such words or by similar expressions. There can be no assurances
that forward-looking statements will be achieved. By their very nature, forward-looking statements
involve known and unknown risks, uncertainties and other important factors that could cause our
actual results or performance to differ materially from those expressed or implied by such
forward-looking statements. Important risks, uncertainties and other factors that could cause our
actual results or performance to differ materially from our forward-looking statements include, among others:
•
risks relating to the filing of our SEC reports, including the occurrence of
known contingencies or unforeseen events that could delay our filings, management
distractions, and significant expense;
•
risk associated with the SEC's initiation of an administrative proceeding on
March 3, 2010 to suspend or revoke the registration of our common stock under the
Exchange Act due to our previous failure to file an annual report on either Form
10-K or Form 10-KSB since April 25, 2005 or quarterly reports on either Form 10-Q
or Form 10-QSB since December 12, 2005;
•
risk that our credit rating could be downgraded or placed on a credit watch
based on, among other things, our financial results, delays in the filing of our
periodic reports, or the results of the SEC's administrative proceeding;
•
risks associated with being a consolidated, controlled subsidiary of Comverse
Technology, Inc., or Comverse, and formerly part of Comverse's consolidated tax
group, including risk of any future impact on us resulting from Comverse's special
committee investigation and restatement or related effects, and risks related to
our dependence on Comverse to provide us with accurate financial information,
including with respect to stock-based compensation expense and net operating loss
carryforwards, or NOLs, for our financial statements;
•
uncertainty regarding the impact of general economic conditions, particularly in
information technology spending, on our business;
•
risk that our financial results will cause us not to be compliant with the
leverage ratio covenant under our credit facility or that any delays in the filing
of future SEC reports could cause us not to be compliant with the financial
statement delivery covenant under our credit facility;
•
risk that customers or partners delay or cancel orders or are unable to honor
contractual commitments due to liquidity issues, challenges in their business or
otherwise;
•
risk that we will experience liquidity or working capital issues and related
risk that financing sources will be unavailable to us on reasonable terms or at
all;
•
uncertainty regarding the future impact on our business of our internal
investigation, restatement, extended filing delay, and the SEC's administrative
proceeding, including customer, partner, employee, and investor concern, and
potential customer and partner transaction deferrals or losses;
•
risks relating to the remediation or inability to adequately remediate material
weaknesses in our internal controls over financial reporting and relating to the
proper application of highly complex accounting rules and pronouncements in order
to produce accurate SEC reports on a timely basis;
•
risks relating to our implementation and maintenance of adequate systems and
internal controls for our current and future operations and reporting needs;
2
Table of Contents
•
risk of possible future restatements if the processes used to produce the
financial statements contained in our SEC reports are inadequate;
•
risk associated with current or future regulatory actions or private litigations
relating to our internal investigation, restatement or previous delay in timely making
required SEC filings;
•
risk that we will be unable to maintain the listing of our common stock on the
NASDAQ Global Market;
•
risks associated with Comverse controlling our board of directors and a majority
of our common stock (and therefore the results of any significant stockholder
vote);
•
risks associated with significant leverage, resulting from our current debt
position;
•
risks due to aggressive competition in all of our markets, including with
respect to maintaining margins and sufficient levels of investment in the business
and with respect to introducing quality products which achieve market acceptance;
•
risks created by continued consolidation of competitors or introduction of large
competitors in our markets with greater resources than us;
•
risks associated with significant foreign and international operations,
including exposure to fluctuations in exchange rates;
•
risks associated with complex and changing local and foreign regulatory
environments;
•
risks associated with our ability to recruit and retain qualified personnel in
all geographies in which we operate;
•
challenges in accurately forecasting revenue and expenses;
•
risks associated with acquisitions and related system integrations;
•
risks relating to our ability to improve our infrastructure to support growth;
•
risks that our intellectual property rights may not be adequate to protect our
business or that others may make claims on our intellectual property or claim
infringement on their intellectual property rights;
•
risks associated with a significant amount of our business coming from domestic
and foreign government customers;
•
risk that we improperly handle sensitive or confidential information or
perception of such mishandling;
•
risks associated with dependence on a limited number of suppliers for certain
components of our products;
•
risk that we are unable to maintain and enhance relationships with key
resellers, partners and systems integrators; and
•
risk that use of our NOLs or other tax benefits may be restricted or eliminated
in the future.
You should carefully review the section entitled "Risk Factors" beginning on page 4 of this
prospectus and the other risk factors set forth in our periodic and other filings with the SEC,
including those set forth in our Annual Report on Form 10-K for the year ended January 31,
2010, for a discussion of these and other risks that relate to our business and an investment in
shares of our common stock. Investors are cautioned not to place undue reliance on forward-looking
statements, which reflect our management's view only as of the date of such statements.
We make no commitment to revise or update any forward-looking statements in order to reflect
events or circumstances after the date any such statement is made, except as otherwise required
under the federal securities laws. If we were in any particular instance to update or correct a
forward-looking statement, investors and others should not conclude that we would make additional
updates or corrections thereafter except as otherwise required under the federal securities laws.
3
Table of Contents
RISK FACTORS
Investing in shares of our common stock involves a high degree of risk. You should carefully
review the risks described below and the other risk factors set forth in our periodic and other
filings with the SEC, including those set forth in our Annual Report on
Form 10-K
for the
year ended January 31, 2010, together with the other information contained in and incorporated by
reference into this prospectus, before making an investment decision. Our business, results of
operations and financial condition may be materially and adversely affected due to any of these
risks. The trading price of our shares could decline due to any of these risks, and you could lose
all or part of your investment. Some risk factors in this section are "forward-looking
statements." See "Cautionary Note on Forward-Looking Statements."
Risks Relating To Our Common Stock
We may not pay dividends on our common stock for the foreseeable future.
We intend to retain our earnings to support the development and expansion of our business, to
repay debt and for other corporate purposes and, as a result, we do not plan to pay cash dividends
on our common stock in the foreseeable future. Our payment of any future dividends will be at the
discretion of our board of directors after taking into account various factors, including our
financial condition, operating results, cash needs, growth plans and the terms of any credit
facility or other restrictive debt agreements that we may be a party to at the time or senior
securities we may have issued. Our current credit facility limits us from paying cash dividends or
other payments or distributions with respect to our capital stock. In addition, the terms of any
future facility or other restrictive debt credit agreement may contain similar restrictions on our
ability to pay any dividends or make any distributions or payments with respect to our capital
stock. In addition, holders of our outstanding preferred stock are entitled to cumulative dividends
before any dividends may be declared or set aside on our common stock.
Furthermore, our ability to pay dividends to our stockholders is subject to the restrictions
set forth under Delaware law. We cannot assure you that we will meet the criteria specified under
Delaware law in the future, in which case we may not be able to pay dividends on our common stock
even if we were to choose to do so.
The price of our common stock fluctuates significantly, and this may make it difficult for you
to resell the common stock when you want to or at prices you find attractive.
There has been significant volatility in the market price and trading volume of equity
securities, including our common stock, some of which is unrelated to the financial performance of
the companies issuing the securities. The price for the shares of common stock being sold under
this prospectus may not be indicative of prices that will prevail in the open market following your
purchase of such shares. You may not be able to resell your shares at or above the price you paid
due to fluctuations in the market price of our common stock caused by changes in our operating
performance or prospects and other factors.
Some specific factors that may have a significant effect on our common stock market price
include:
•
actual or anticipated quarterly fluctuations in our operating and financial
results;
•
developments related to investigations, proceedings or litigation that involve
us;
•
changes in financial estimates and recommendations by financial analysts;
•
dispositions, acquisitions, and financings;
•
actions of our current stockholders, including sales of our common stock by
existing stockholders and our directors and executive officers;
•
success of competitive service offerings or technologies;
•
fluctuations in the stock price and operating results of our competitors;
•
investors' general perception of us;
4
Table of Contents
•
regulatory developments; and
•
developments related to the industries in which we compete.
Because our common stock has only been re-listed on the NASDAQ Global Market since July 6,
2010, we cannot predict the extent to which investor interest in our company will lead to the
development of an active trading market on the NASDAQ Global Market or otherwise or how liquid that
market might become. Unless there is an active trading market for our common stock, you may have
difficulty selling any of our common stock that you purchase. Consequently, you may not be able to
sell our common stock at prices equal to or greater than the price you paid.
If we or our stockholders sell substantial amounts of our common stock following the sale of the
shares of common stock being sold under this prospectus, the market price of our common stock
may decline.
We are not restricted from issuing additional shares of common stock, including shares
issuable pursuant to securities that are convertible into or exchangeable for, or that represent
the right to receive, common stock. Sales of shares of our common stock in the public market
following the sale of the shares of common stock being sold under this prospectus, or the
perception that these sales may occur, could cause the market price of our common stock to decline.
We had 33,042,345 shares of common stock outstanding as of
June 30, 2010. In addition, at June 30, 2010, 8,916,086
shares of our common stock (including 1,269,894 of the shares included in this prospectus
which were acquired by the selling stockholders on July 2, 2010
and July 6, 2010) were issuable pursuant to outstanding stock
options and awards which had
not yet vested or which had been previously acquired upon vesting but had not yet been delivered.
Moreover, if it were convertible at June 30, 2010, our outstanding preferred stock could be
converted into 10,072,966 shares of our common stock. Additional shares of common stock underlying
options and restricted stock units available to be granted in the
future will become available for sale in the public market.
In addition,
under two registration rights agreements that we entered into with Comverse,
Comverse has registration rights, with respect to its common stock and preferred stock,
and future offerings of our common stock could result in sales
of significant amounts of our common stock.
Anti-takeover provisions in Delaware corporate law may make it difficult for our stockholders to
replace or remove our current board of directors and could deter or delay third-parties from
acquiring us, which may adversely affect the marketability and market price of our common stock.
We are subject to the anti-takeover provisions of Section 203 of the Delaware General
Corporation Law. Under these provisions, if anyone becomes an "interested stockholder," we may not
enter into a "business combination" with that person for three years without special approval,
which could discourage a third party from making a takeover offer and could delay or prevent a
change of control. For purposes of Section 203, "interested stockholder" means, generally, someone
owning more than 15% or more of our outstanding voting stock or an affiliate of ours that owned 15%
or more of our outstanding voting stock during the past three years, subject to certain exceptions
as described in Section 203.
Under any change of control, the lenders under our credit facilities would have the right to
require us to repay all of our outstanding obligations under the facility. Upon the occurrence of a
"Fundamental Change", as defined by the Certificate of Designation setting forth the terms of the
preferred stock, and which includes a change of control, the holders of our preferred stock have
the right to require us to repurchase their shares of preferred stock at the then current
liquidation preference (subject to certain exceptions set forth in the Certificate of Designation).
Holders of our preferred stock have liquidation and other rights that are senior to the rights
of the holders of our common stock.
Our board of directors has the authority to designate and issue preferred stock that may have
dividend, liquidation and other rights that are senior to those of our common stock. As of date of
this prospectus, 293,000 shares of our preferred stock have been issued and are outstanding.
Holders of our preferred stock are entitled to cumulative dividends before any dividends may be
declared or set aside on our common stock. Upon our voluntary or involuntary liquidation,
dissolution or winding up, before any payment is made to holders of our common stock,
holders of our preferred stock are entitled to receive an initial liquidation preference of
$1,000 per share, plus any accrued and unpaid dividends. This will reduce the remaining amount of
our assets, if any, available to distribute to holders of our common stock.
5
Table of Contents
USE OF PROCEEDS
We will not receive any proceeds from sales of the shares of our common stock covered by this
prospectus by any of the selling stockholders. The proceeds from the sale of the common stock
covered by this prospectus are solely for the accounts of the selling stockholders.
We will bear all costs, expenses and fees in connection with the registration of the shares.
Brokerage commissions and similar selling expenses, if any, attributable to the offer or sale of
the shares will be borne by the selling stockholders.
6
Table of Contents
SELLING STOCKHOLDERS
This prospectus relates to shares of our common stock previously issued pursuant to the Plans
to certain of our officers, directors and employees that are being registered for resale. All of
the shares of common stock that may be resold pursuant to this prospectus were previously acquired
by the selling stockholders upon the satisfaction of applicable vesting conditions relating to
certain equity awards (i.e., the re-listing of our common stock on the NASDAQ Global Market
and/or the passage of time).
The selling stockholders may resell any or all of such shares of common stock at any time they
choose while this prospectus is effective. The inclusion in this prospectus of the officers,
directors and employees named below who have acquired shares of our common stock under the Plans
shall not be deemed to be an admission that any such individual is an "affiliate" of ours. There
is no assurance that any of the selling stockholders will sell any or all of the shares of common
stock covered by this prospectus.
Shares
of Common Stock Offered for Resale by Officers and Directors
The following table sets forth the following information to the
extent known to the Company as
of July 6, 2010 with respect to the shares of common stock previously issued under the Plans held
by each selling stockholder who is an officer or director of the Company:
•
the name of such selling stockholder and the principal position or positions
with the Company held by such selling stockholder within the past three years;
•
the number and percentage of shares of our common stock such selling stockholder
beneficially owned as of July 6, 2010;
•
the number of shares of our common stock to be offered for resale by such
selling stockholder in this offering; and
•
the number and percentage of shares of our common stock to be beneficially owned
by such selling stockholder after completion of this offering.
As used in following table, "beneficial ownership" is determined in accordance with Rule 13d-3
under the Exchange Act and means the sole or shared power to vote or direct the voting or to
dispose or direct the disposition of any equity security. A person is deemed to be the beneficial
owner of securities that he has the right to acquire within 60 days of July 6, 2010 through the
exercise of any option, warrant or right.
The address of each selling stockholder listed in the following table is c/o Verint Systems
Inc., 330 South Service Road, Melville, New York 11747.
Shares of Common Stock
Shares of
Shares of Common Stock
Beneficially Owned as of
Common
Beneficially Owned After the
July 6,
2010 (1) (2)
Stock to be
Offering (1)(3)
Name
Position
Number
Percentage (4)
Sold
Number
Percentage (4)
Dan Bodner
President, Chief Executive Officer, Corporate Officer,
and Director
592,383
1.7
%
227,074
365,309
(5)
1.0
%
Victor A. DeMarines
Director
34,000
*
17,000
17,000
(6)
*
Peter Fante
Chief Legal Officer, Chief
Compliance Officer,
Secretary, and
Corporate Officer
128,029
*
76,794
51,235
(7)
*
Kenneth A. Minihan
Director
35,000
*
17,000
18,000
(8)
*
Elan Moriah
President, Verint Witness Actionable
Solutions and
Verint Video Intelligence
Solutions and
Corporate Officer
199,992
*
92,186
107,806
(9)
*
Larry F. Myers
Director
23,000
*
17,000
6,000
(10)
*
7
Table of Contents
Shares of Common Stock
Shares of
Shares of Common Stock
Beneficially Owned as of
Common
Beneficially Owned After the
July 6, 2010 (1) (2)
Stock to be
Offering (1)(3)
Name
Position
Number
Percentage (4)
Sold
Number
Percentage (4)
David Parcell
Managing Director, Europe, the Middle East, and Africa, and Corporate Officer
111,701
*
63,561
48,140
(11)
*
Douglas E. Robinson
Chief Financial Officer and
Corporate Officer
105,605
*
100,005
5,600
(12)
*
Howard Safir
Director
40,000
*
17,000
23,000
(13)
*
Meir Sperling
President, Verint Communications
Intelligence and
Investigative
Solutions and
Corporate Officer
221,922
*
102,030
119,892
(14)
*
*
Less than 1%.
(1)
Unless otherwise indicated, includes shares beneficially owned by a spouse, minor children
and relatives sharing the same home, as well as entities owned or controlled by the named
person.
(2)
The amounts appearing in this column
reflect the "Shares of Common Stock to be Sold" plus the "Shares
of Common Stock Beneficially Owned After the Offering."
(3)
Assumes the selling stockholders sell all of the shares of our common stock covered by this
prospectus.
(4)
Applicable percentage of ownership is based on 33,042,345 shares of our common stock issued
and outstanding as of June 30, 2010 plus an additional
1,505,326 of the shares of our common
stock that may be offered pursuant to this prospectus that were acquired by the selling
stockholders on July 2, 2010 and July 6, 2010 or shares which have been previously acquired
upon vesting but have not yet been delivered, for a total of
34,547,671 shares. Because our
preferred stock is not currently convertible, the 10,072,966 shares of common stock that would
be issuable upon conversion of shares of our outstanding preferred stock (if converted on
June 30, 2010) are not included in this number. Additionally, shares of our common stock subject to options, warrants, or rights which are currently exercisable or
exercisable within 60 days are deemed outstanding for computing the ownership percentage of the person holding such
options, warrants, or rights, but are not deemed outstanding for computing the ownership percentage of any other
person.
(5)
Includes options to purchase 261,835 shares of common stock
which are currently exercisable. Includes 103,474 shares of
restricted stock which are fully vested.
(6)
Consists of options to purchase 17,000 shares of common stock that are currently exercisable.
(7)
Includes options to purchase 45,000 shares of common stock
which are currently exercisable. Includes 6,235 shares of restricted
stock which are fully vested.
(8)
Consists of options to purchase 18,000 shares of common stock that are currently exercisable.
(9)
Includes options to purchase 91,088 shares of common stock
which are currently exercisable. Includes 16,718 shares of restricted
stock which are fully vested.
(10)
Consists of options to purchase 6,000 shares of common stock that are currently exercisable.
(11)
Includes options to purchase 41,196 shares of common stock
which are currently exercisable. Includes 6,944 shares of restricted
stock which are fully vested.
(12)
Includes 5,600 restricted stock unit awards that will vest within 60 days of
July 6, 2010.
(13)
Consists of options to purchase 23,000 shares of common stock that are currently exercisable.
(14)
Includes options to purchase 99,892 shares of common stock
which are currently exercisable. Includes 20,000 shares of restricted
stock which are fully vested.
8
Table of Contents
Shares of Common Stock
Offered for Resale by Non-Officer Employees
The following is a list of all non-officer employees, regardless of number of shares held, who
previously acquired shares of our common stock in connection with the relisting of our common stock
on the NASDAQ Global Market on July 6, 2010, pursuant to awards previously granted under the Plans.
These non-officer employees may sell up to an aggregate of 1,083,484 shares of common stock,
representing 3.1% of our issued and outstanding shares of common stock. This percentage of
ownership is based on 33,042,345 shares of our common stock issued and outstanding as of June 30,
2010 plus an additional 1,505,326 of the shares of our common stock that may be offered pursuant to
this prospectus that were acquired by the selling stockholders on July 2, 2010 and July 6, 2010 or
shares which have been previously acquired upon vesting but have not yet been delivered, for a
total of 34,547,671 shares.
Emil Abramovich
Ran Achituv
Gil Adda
Mohit Aggrwal
Lynn Akers
Shay Akiva
Oscar A. Alban
Caroline Albert
Yuval Altman
Yaniv Amir
Yair Amsterdam
James Anderson
Zafrir Argov
Yoav Ariav
Eli Arman
Barbara Arndt
Sunil Aryan
Kar Ashutosh
Richard Philip Avenell
Amir Avrahami
Eyal Bachar
John William Bailey
Dror Bareket
Gustavo Baril
Robert John Barnes
Todd Barrick
Bryan Beach
Pedro Becquer
Gali Begas
Yanai Beilis
Natalie Bell
Stephen Bell
Merav Ben Rehav
Zwicka Ben Zion
Avishay Ben Zvi
Tami Ben-Jacob
Zalman Ben-Meir
Evyatar Ben-Shitrit
Asaf Ben-Zeev
David J. Bertolino
Shimon Bezalel
Michael Birdsong
Amit Bishoni
Dennis Blanco
Amy Blank
Scott Bluman
Cletus F. Bordeaux
Katherine Bost
Jean Boudreau
John R. Bourne
Craig Douglas Braisby
Richard Branchaud
Oren Bregman
Arie Briness
Josef Bronstein
Neri Brutzkus
Yossi Bulwik
Lawrence T. Butsch
William K. Byleveld
Marc Calahan
Joseph Carley
Brian Carman
Saar Carmi
Dorit Carmon
Ido Carmon
Kenneth Carney
William Stuart Caton III
Yossi Chai
Andrew Ming Keung Chan
Eva Charissakis
Woon Ming Charles Cheng
Chong Va Cheong
Sophie Chetboun
Sharon Chouli
Anthony Cintado
Itzik Cohen
Nir Cohen
Tzachi Cohen
Yaniv Cohen
Donna Colby
Gail Cole
David C. Copeland
Sue Cordaro
John Crosby
Owen Crossweller
Patrick Dagenais
Ernest D'Ambrose
Koby Danon
Shlomo Davidesco
Ran Davidovitz
Andrew Davies
Ajay Dawar
Frank Deans
Liberato Degruttola
Jose DeJesus
Kaushik Deka
Snehal Desai
Aude Desbrieres
Daniel Di Cicco
Michael DiBiase
Debra DiGianno
Marc Dittmer
Nancy DiVito
Thomas Dong
Boaz Dudovich
Gary Andrew Duke
John Christopher Duncan
Richard DuPree Jr.
William Durr
William L. Eckard III
Natalie Eckel
Charles Ehlers
Itzik Eidelman
Robert Eilbacher
Moshe Ekroni
Itai Elata
Amos Eliav
Miki Epstein
Ron Epstein
Benzi Falik
Jim Jianrong Fan
Richard Fietz
Boaz Fischer
Henrich Fischler
Karen Flynn
Stephen Foley
Paul Fournier
Michael Fox
Inbar Fridman
Michael Gagnon
Mike Gale
Ronen Galitzki
Zack Galon
Siddartha Gandhi
David Ganon
Joel Garnatz
Simon Gauthier
Smadar Gazit
Zoe Gee
Shimi Gil
Asaf Gilai
Darren Gill
Yossi Glass
Igor Goldberg
Royee Goldberg
Shay Gonen
Nicolas Gonthier
Kevin Graham Gower
Michael Graci
Ian Graham
Juliet P. Gram
Dov Granot
Moshe Granot
Marc Graveline
Richard Green
Galit Greenbaum
Kondal Gundla
Rajan Gupta
James Hagen
Eran Halfon
Eyal Halfon
Olaf Hansen
Andy Harper
Marcia J. Harris
Amy Conroy Hassinger
Andrew Robert Hawkes
Nati Hayun
Inon Hefetz
Kurt Allen Heier
Wallace Henderson
Nigel Christopher Hewett
Lior Hipsh
Tim Neil Holland
Ryan W. Hollenbeck
Andrew John Holmes
Itsik Horovitz
Gabriel Horowitz
Michael Howanitz
Jacqueline C. Hudson
Gary W. Humphrey
Susan Huston
Ofer Iankovitch
Rick V. Israel
9
Table of Contents
Philip Ives
Thomas Lyerly
Colin Maurice Pope
Hugo Jacques
Fiona Bridget Lynch
Ken Porter
Guy Jacubovski
Tarun Mahajan
Sean Quigley
Ron Jenik
Genady Malinsky
Avi Rabinovich
Jay Jennings
Zahi Malki
Elad Rachamim
Alexander Steven Johnson
Michel J. Manche
Marc Racicot
Alush Joni
Louis Marchand
Fred Radley
Jeff D. Jue
Eran Marelly
Gaurav Rastogi
Steve Kaden
Hugo Martel
Serena Rayner
Rafael Kaduri
Roderick Matheson III
Shay Razon
Hitpreet Kang
Sheryl Mattison
Alexander Reizis
David Kashak
Mary Christine McAleer
Shahar Remets
Ronen Katav
John McCourt
Lance Richardson
Eyal Katz
Todd McDermott
John Ringelman
Ziv Katzir
Nick Alexander McLean
Carl David Robson
Dana Katznelson
Maureen E. McMahon
Matthew Robson
Nhevo Kaufman
Yossi Medina
Or Rochman
Ron Keidar
Nikola Meldrum
Daniel Rock
Persephone Keller
Yuval Meron
Alan J. Roden
Shimon Keren
Kevin Moore
Nita Rodriguez
Lior Kessel
Gilad Mor
Bryan Melvyn Rose
Giles King
James Moretti
Brigitte Routhier
Yaron Klein
Michel Morneau
Shaul Rudnitsky
Yaniv Knany
Erez Nadav
Kurt Rush
Nicholas Kocaj
Harish Nair
Elizabeth Russell
Jonathan Kohl
Paul Najdzin
Greg Ruzicka
Willie Kouncar
Joseph Neer
William Ryan
Greg Krebs
Nir Nehmad
Tom Sabga
Kevin Kurimsky
Yossi Nelkenbaum
Bernard Sarel
Adam Wan Fung Kwok
Christopher Nelson
William D. Schneider
Wai Chung Lam
Orna Neuman
Ann Marie Schumann
Charles Gregory Lampe
Kasey Newman
Craig Seebach
Ronen Lampert
Kimball Newman
Noam Seelenfreund
Arik Landau
James Nies
Ado Segal
Robert Lander
Roi Nobel
Ian Sephton
Jim Langley Sr.
Roy Nugent
Irit Shaaya-Segal
Athena Larsen
Efi Nuri
Manishkumar Rameschandra Shah
Erik Laurence
Robert Nyberg
Guy Shahmoon
Marco Leclerc
Jane O'Donnell
Naama Shalom
Chi Kin Lee
Johnathan Oelsner
Elad Sharon
Tibor Leibovitch
Yuval Ohana
Omer Shavit
Ilan Leizgold
Christopher Orr
Terry Sheehan
Brian Leslie
Yoni Osherov
Karim Shehadeh
Eli Lessel
William Pardue
Eran Shehori
Willy Chun Bong Leung
Rob Parkinson
Ariel Shemesh
Yan Lev
Dhiren Patel
Nick Shepherd
Eli Levi
Anne M Patton
Jim Sherring
Shai Levi
Norvel Patton
Gregory Sherry
I. Craig Levin
Paul Patton
Tal Shtauber
Golan Levy
Shefi Paz
Shlomit Shteyer
Shaked Levy
Noam Pelles
Wee Kiat Sim
Amanda Lewis
Jose Fortuna Penaredondo
Ziv Simhon
Vincent Licciardi
Nir Pery
David Singer
Leslie Linsner
Shlomo Pesach
Eli Sinianski
Shlomit Littig
Niv Peskin
Man Ho Sit
Haim Litvak
Krishna Pisipati
Damian Smith
Nataly Loewidt
Marcel Poirier
Robyn Smith
10
Table of Contents
Yehuda Sorek
Gary S. Trudo
Wayne Willis
Barry Spielman
Shiu Hang Kenneth Tsang
Jon Wilson
Rodrigo Spinelli
Stephanie Turner
Rob Wint
Daniel Spohrer
Yossi Twizer
Christopher Wood
Kevin J. Steel
Shiri Tzuk
David Worthley
Oren Stern
Thomas D. Ulreich
Duane Sherrington Wright
Andre St-Jean
Yitzhak Vager
Gur Yaari
David Stone
Joseph P. Vidunas
Gadi Yair
Kevin Strange
Daniel Vitlis
Doron Yankovitch
Bradley Stratton
Brad Von Tersch
Trent Yarbrough
Edgar E. Suarez
Joanne Voorhees
Danny Yaron
Dana Sugarman
John Voyatzis
Aliaksei Yermakov
David Suttle
Helen Vuletin
Yossi Yitshaki
Ram Swery
Eran Wachman
Koby Yosef
Edward Syphers
Mohammed Waseem
Dganit Zahavi
Nimrod Tabenkin
Joseph Watson
Christopher L. Zaske
Shimi Tal
Lori Weight
Ruthi Zimmerman
Guy Tamir
Dikla Weininger
Amir Zipori
Erez Taoz
Daniel Weiss
Dror Daniel Ziv
Cheryle Tapp
Miki Weiss
Yoel Zmuckas
Ryan Tate
Zvi Weiss
Yoram Zohar
Nitzan Tau
Peter Weller
Eytan Zucker
Matthew Paul Tengwall
Steve Weller
Alexander Zur
Simon Thewes
Daniel Wensel
Dror Zur
Guy Toibin
Wynne Wilder
Ido Zur
Nancy Y. Treaster
Timothy Wilkie
Vladimir Trostyanetski
Jamie Williams
11
Table of Contents
PLAN OF DISTRIBUTION
The selling stockholders have not advised us of any specific plan for the sale or distribution
of the shares of common stock covered by this prospectus. If and when they occur, such sales may be
made in any of the following manners:
•
On the NASDAQ Global Market (or through the facilities of any national
securities exchange or U.S. inter-dealer quotation system of a registered national
securities association on which shares of our common stock are then listed,
admitted to unlisted trading privileges or included for quotation);
•
in public or privately negotiated transactions;
•
in transactions involving principals or brokers;
•
in a combination of such methods of sale; or
•
any other lawful methods.
Although sales of the shares of common stock covered by this prospectus are, in general,
expected to be made at market prices prevailing at the time of sale, the shares may also be sold at
prices related to such prevailing market prices or at negotiated prices, which may differ
considerably.
When offering the shares of common stock covered by this prospectus, each of the selling
stockholders and any broker-dealers who sell the shares for the selling stockholders may be
"underwriters" within the meaning of the Securities Act, and any profits realized by such selling
stockholders and the compensation of such broker-dealers may be underwriting discounts and
commissions.
Sales through brokers may be made by any method of trading authorized by any stock exchange or
market on which our common stock may be listed, including block trading in negotiated transactions.
Without limiting the foregoing, such brokers may act as dealers by purchasing any or all of the
shares of common stock covered by this prospectus, either as agents for others or as principals for
their own accounts, and reselling such shares pursuant to this prospectus. The selling stockholders
may effect such transactions directly, or indirectly through underwriters, broker-dealers or agents
acting on their behalf. In connection with such sales, such broker-dealers or agents may receive
compensation in the form of commissions, concessions, allowances or discounts, any or all of which
might be in excess of customary amounts.
Each of the selling stockholders is acting independently of us in making decisions with
respect to the timing, manner and size of each sale of shares. We have not been advised of any
definitive selling arrangement at the date of this prospectus between any selling stockholder and
any broker-dealer or agent.
To the extent required, the names of any agents, broker-dealers or underwriters and applicable
commissions, concessions, allowances or discounts, and any other required information with respect
to any particular offer of the shares by the selling stockholders, will be set forth in a
prospectus supplement.
The expenses of preparing and filing this prospectus and the related registration statement
with the SEC will be paid entirely by us. The selling stockholders have been advised that they are
subject to the applicable provisions of the Exchange Act, including without limitation Rule 10b-5
thereunder.
Neither we nor the selling stockholders can currently estimate the amount of commissions or
discounts, if any, that will be paid by the selling stockholders on account of their sales of the
shares from time to time.
12
Table of Contents
LEGAL MATTERS
The validity of the issuance of the shares of common stock offered in this prospectus will be
passed upon for us by Jones Day, New York, New York.
EXPERTS
The
consolidated financial statements, incorporated in this prospectus by reference from Verint Systems Inc.'s Annual
Report on Form 10-K for the year ended January 31, 2010, and the
effectiveness of Verint Systems Inc.'s internal control
over financial reporting have been audited by Deloitte & Touche LLP, an independent registered public accounting firm,
as stated in their reports, which are incorporated herein by reference (which reports (1) express an unqualified
opinion on the consolidated financial statements and include an explanatory paragraph relating to the adoption of new
accounting guidance for the reporting and disclosure of noncontrolling interests, and (2) express an adverse opinion on
the effectiveness of Verint Systems Inc.'s internal control over financial reporting because of material weaknesses).
Such consolidated financial statements have been so incorporated in reliance upon the reports of such firm given upon
their authority as experts in accounting and auditing.
INFORMATION INCORPORATED BY REFERENCE
The SEC allows us to incorporate by reference certain of our publicly filed documents into
this prospectus, which means that we can disclose important business and financial information to
you that is not included in or delivered with this prospectus by referring you to publicly filed
documents that contain the omitted information. The information incorporated by reference is
considered to be part of this prospectus, and any later information that we file with the SEC will
automatically update and supersede this information. You will be deemed to have notice of all
information incorporated by reference into this prospectus as if that information were included in
this prospectus.
The following documents that we have filed with the SEC are incorporated herein by reference:
•
our Annual Report on Form 10-K for the year ended January 31, 2010, filed
with the SEC on May 19, 2010;
•
our Quarterly Report on Form 10-Q for the quarterly period ended April 30, 2010,
filed with the SEC on June 9, 2010;
•
our Current Reports on Form 8-K, filed with the SEC on
February 4, 2010, February 23, 2010, March 3, 2010, March 22,
2010, April 21, 2010 and May 3, 2010; and
•
the description of our common stock, par value $0.001, per share, contained in our
Registration Statement on Form 8-A, filed with the SEC on July 2, 2010.
Except as otherwise indicated, all documents we file with the SEC pursuant to Sections 13(a),
13(c), 14 and 15(d) of the Exchange Act subsequent to the date of this prospectus and prior to the
filing of a post-effective amendment that indicates that all securities offered have been sold or
that deregisters all securities then remaining unsold will be deemed to be incorporated by
reference into this prospectus and to be part hereof from the date of filing of such documents.
Any statement contained in any document incorporated or deemed to be incorporated by reference
herein will be deemed to be modified or superseded for purposes of this prospectus to the extent
that a statement contained herein or in any other subsequently filed document which also is or is
deemed to be incorporated by reference herein modifies or supersedes such statement. Any such
statement so modified or superseded will not be deemed, except as modified or superseded, to
constitute a part of this prospectus. This prospectus is part of a Registration Statement on Form
S-8 that we filed with the SEC and does not contain all of the information set forth in that
Registration Statement.
We will provide, free of charge, to any person to whom a copy of this prospectus is delivered,
upon written or oral request, a copy of any or all of the documents incorporated by reference into
this prospectus, other than exhibits to those documents unless specifically incorporated by
reference. To request a copy of those documents, you should contact us at the address set forth
below under "Where You Can Find Additional Information."
13
Table of Contents
WHERE YOU CAN FIND ADDITIONAL INFORMATION
We file annual, quarterly and current reports, proxy statements and other information with the
SEC. The SEC allows us to incorporate by reference the information we file with them, which means
that we can disclose important business and financial information to you that is not included in or
delivered with this prospectus by referring you to publicly filed documents that contain the
omitted information. We provide a list of all documents we incorporate by reference into this
prospectus under "Information Incorporated by Reference" above.
Through our website at www.verint.com, we make available the information that we incorporate
by reference into this prospectus, as well as other reports, proxy statements and other information
that we file with the SEC. You may also read and copy those materials at the SEC's Public
Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at (800) SEC-0330
for further information on the operation of the Public Reference Room. In addition, we are required
to file electronic versions of those materials with the SEC through the SEC's EDGAR system. The SEC
maintains a website at www.sec.gov that contains reports, proxy statements and other information
that registrants, such as we, file electronically with the SEC. Our website address set forth
above is not intended to be an active link, and information on our website is not incorporated in,
and should not be construed to be a part of, this prospectus.
Each person to whom a prospectus is delivered may also request a copy of those materials, free
of charge, by contacting us at the following address:
Verint Systems Inc.
330 South Service Road
Melville, New York 11747
(631) 962-9600
Attn: Corporate Secretary
14
Table of Contents
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents filed by the Company with the Commission are incorporated herein by
reference:
•
the Company's Annual Report on Form 10-K for the year ended January 31, 2010,
filed with the Commission on May 19, 2010;
•
the Company's Quarterly Report on Form 10-Q for the quarterly period ended April 30,
2010, filed with the Commission on June 9, 2010;
•
the Company's Current Reports on Form 8-K, filed with
the Commission on February 4, 2010, February 23, 2010,
March 3, 2010, March 22, 2010, April 21, 2010 and May 3, 2010; and
•
the description of the Company's common stock, par value $0.001, per share,
contained in the Registrant's Registration Statement on Form 8-A, filed with the
Commission on July 2, 2010.
All documents filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14
and 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), subsequent to
the date of this Registration Statement and prior to the filing of a post-effective amendment that
indicates that all securities offered have been sold or which deregisters all securities then
remaining unsold will be deemed to be incorporated by reference in this Registration Statement and
to be part hereof from the date of filing of such documents. Any statement contained in any
document incorporated or deemed to be incorporated by reference herein will be deemed to be
modified or superseded for purposes of this Registration Statement to the extent that a statement
contained herein or in any other subsequently filed document which also is or is deemed to be
incorporated by reference herein modifies or supersedes such statement. Any such statement so
modified or superseded will not be deemed, except as modified or superseded, to constitute a part
of this Registration Statement.
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts and Counsel.
Not applicable.
Item 6. Indemnification of Directors and Officers.
Section 102 of the Delaware General Corporation Law (the "DGCL") allows a corporation to
eliminate the personal liability of directors of a corporation to the corporation or its
stockholders for monetary damages for breach of fiduciary duty as a director, except where the
director breached the duty of loyalty, failed to act in good faith, engaged in intentional
misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock
repurchase in violation of the DGCL or obtained an improper personal benefit.
Section 145 of the DGCL provides, among other things, that the Company may indemnify any
person who was or is a party or is threatened to be made a party to any threatened, pending or
completed action, suit or proceeding other than an action by or in the right of the Company, by
reason of the fact that the person is or was a director, officer, agent or employee of the Company,
or is or was serving at the Company's request as a director, officer, agent or employee of another
corporation, partnership, joint venture, trust or other enterprise, against expenses, including
attorneys' fees, judgments, fines and amounts paid in settlement actually and reasonably incurred
by the person in connection with such action, suit or proceeding, if such person acting in good
faith and in a manner he or she reasonably believed to be in the best interest, or not opposed to
the best interest, of the Company, and with respect to any criminal action or proceeding had no
reasonable cause to believe his or her conduct was unlawful. The power to indemnify applies to
actions brought by or in the right of the Company as well, but only to the extent of defense
expenses, including attorneys' fees, actually and reasonably incurred in connection with the
defense or settlement of such action or suit, and with the further limitation that in such actions
no indemnification shall be made in respect of any claim, issue or matter as to which any person
shall have been adjudged liable to the Company, unless the court believes that in light of all the
circumstances indemnification should apply. Furthermore, under the DGCL, if such person is
successful on the merits or otherwise in the defense of any action referred to above, or in the
defense of any claim, issue or matter therein, such person shall be indemnified against expenses
(including attorneys' fees) actually and reasonably incurred by such person in connection
therewith.
II-1
Table of Contents
Section 174 of the DGCL provides, among other things, that a director, who willfully or
negligently approves of an unlawful payment of dividends or an unlawful purchase or redemption of
stock, may be held liable for such actions. A director who was either absent when the unlawful
actions were approved or dissented at the time, may avoid liability by causing his or her dissent
to such actions to be entered in the books containing minutes of the meetings of the board of
directors at the time such action occurred or immediately after such absent director receives
notice of the unlawful acts.
The above is a general summary of certain indemnity provisions of the DGCL and is subject, in
all cases, to the specific and detailed provisions of the Sections referenced herein.
As permitted by the DGCL, our certificate of incorporation includes a provision to eliminate
the personal liability of our directors for monetary damages for breach or alleged breach of their
fiduciary duties as directors, subject to limited exceptions. Our certificate of incorporation also
provides that every person who is or was our director, officer, employee or agent or is or was a
director, officer, employee or agent of any other enterprise, serving as such at our request, shall
be indemnified to the fullest extent permitted by law for all expenses and liabilities actually and
reasonably incurred in connection with any proceeding involving such person in this capacity. The
Company has also entered into an indemnification agreement with each of its directors and officers under
which the Company agreed to provide indemnification and expense reimbursement as outlined above.
The Company has agreed to indemnify Comverse Technology, Inc. ("Comverse") and its directors,
officers, employees and agents against any liabilities arising out of any claim that any provision
of the business opportunities agreement, entered into by the Company and Comverse, breaches any
duty that may be owed to the Company by Comverse or any such person.
The Company has provided directors' and officers' liability insurance coverage for the
Company's officers and directors since 2006. Previously, Comverse obtained directors' and
officers' liability insurance which also provided coverage for the Company's officers and directors
under a Corporate Services Agreement entered into by the Company and Comverse.
Each of the Company's directors who is also a director and/or officer of Comverse has an
indemnification agreement with Comverse. Under this agreement Comverse has agreed to indemnify
such person against losses and expenses, to the extent permitted by law, incurred by such person in
connection with his service as director and/or officer of Comverse or any of its subsidiaries,
including the Company.
Item 7. Exemption from Registration Claimed.
As previously disclosed, as a result of the Company's inability to file required reports with
the Commission during the Company's extended filing delay
period, the Company previously ceased using its
existing registration statements on Form S-8 to make equity grants to employees. On May 24, 2007,
the Company received a no-action letter from the Commission upon which the Company relied to make
broad-based equity grants to employees under a no-sale theory. The Company has also made equity
grants to directors, executive officers and certain other non-officer executives who qualify as
accredited investors in reliance upon the exemption from registration provided by Regulation D of
the Securities Act of 1933. All of the shares of common stock that may be offered pursuant to this
registration statement were acquired by the selling stockholders upon the
grant of restricted stock pursuant to an applicable private placement exemption or the
vesting of equity awards
issued pursuant to the no-sale theory or an applicable private placement exemption.
II-2
Table of Contents
Item 8. Exhibits.
Filed Herewith /
Incorporated by Reference
Number
Description
from
4.1
Amended and Restated Certificate of Incorporation of Verint
Systems Inc.
Form S-1 (Commission
File No. 333-82300)
effective on May 16,
2002
4.2
Certificate of Designation, Preferences and Rights of the Series A
Convertible Perpetual Preferred Stock
Form 8-K filed on May
30, 2007 8-K
4.3
Amended and Restated By-laws of Verint Systems Inc.
Form 10-K filed on March 17, 2010
4.4
Specimen Common Stock certificate
Form S-1 (Commission
File No. 333-82300)
effective on May 16,
2002
4.5
Specimen Series A Convertible Perpetual Preferred Stock certificate
Form 10-K filed on March 17, 2010
4.6
Verint Systems Inc. Stock Incentive Compensation Plan (as amended
through December 12, 2002)
Form 10-K filed on May
1, 2003
4.7
Amendment No. 1 to Verint Systems Inc. Stock Incentive
Compensation Plan (dated December 23, 2008)
Form 10-K filed on March 17, 2010
4.8
Amendment No. 2 to Verint Systems Inc. Stock Incentive
Compensation Plan (dated March 4, 2009)
Form 10-K filed on March 17, 2010
4.9
Verint Systems Inc. 2004 Stock Incentive Compensation Plan, as
amended and restated
Form 8-K filed on
January 10, 2006
4.10
Amendment No. 1 to Verint Systems Inc. 2004 Stock Incentive
Compensation Plan, as amended and restated (dated December 23,
2008)
Form 10-K filed on March 17, 2010
4.11
Witness Systems Amended and Restated Stock Incentive Plan
Witness Systems, Inc.
Form 10-Q filed on
August 9, 2005
4.12
Amendment No. 1 to Witness Systems Amended and Restated Stock
Incentive Plan (dated May 29, 2001)
Witness Systems, Inc.
Form 10-K filed on March 17, 2006
4.13
Amendment No. 2 to Witness Systems Amended and Restated Stock
Incentive Plan (dated January 15, 2004)
Witness Systems, Inc.
Form 10-K filed on March 15, 2004
4.14
Amendment No. 3 to Witness Systems Amended and Restated Stock
Incentive Plan (dated December 6, 2007)
Form 10-K filed on March 17, 2010
4.15
Amendment No. 4 to Witness Systems Amended and Restated Stock
Incentive Plan (dated December 23, 2008)
Form 10-K filed on March 17, 2010
5.1
Opinion of Jones Day
Filed Herewith
23.1
Consent of Deloitte & Touche LLP
Filed Herewith
23.2
Consent of Jones Day (included in Exhibit 5.1)
Filed Herewith
II-3
Table of Contents
Item 9. Undertakings.
(a) The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a post-effective
amendment to this registration statement:
(i) to include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii) to reflect in the prospectus any facts or events arising after the effective date
of this registration statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the information set
forth in this registration statement; and
(iii) to include any material information with respect to the plan of distribution not
previously disclosed in this registration statement or any material change to such
information in this registration statement;
provided, however
, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the registration
statement is on Form S-8, and the information required to be included in a post-effective amendment
by those paragraphs is contained in reports filed with or furnished to the Commission by the
Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by
reference in this registration statement.
(2) That, for the purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time will be deemed to be
the initial
bona fide
offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the offering.
(b) The undersigned Registrant hereby undertakes that, for purposes of determining any
liability under the Securities Act, each filing of the Registrant's annual report pursuant to
Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an
employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is
incorporated by reference in this registration statement will be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that
time will be deemed to be the initial
bona fide
offering thereof.
(c) Insofar as indemnification for liabilities arising under the Securities Act may be
permitted to directors, officers and controlling persons of the Registrant pursuant to the
foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the
Commission such indemnification is against public policy as expressed in the Securities Act and is,
therefore, unenforceable. In the event that a claim for indemnification against such liabilities
(other than the payment by the Registrant of expenses incurred or paid by a director, officer or
controlling person of the Registrant in the successful defense of any action, suit or proceeding)
is asserted by such director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter has been settled
by controlling precedent, submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Securities Act and will be
governed by the final adjudication of such issue.
II-4
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it
has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and
has duly caused this Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the city of Melville, State of New York, on this 6th day of July,
2010.
VERINT SYSTEMS INC.
By:
/s/ Dan Bodner
Dan Bodner
President and Chief Executive Officer
Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has
been signed by the following persons in the capacities and on the dates indicated.
/s/ Dan Bodner
Dan Bodner, Chief Executive Officer
and President; Director of Verint Systems Inc.
(Principal Executive Officer)
July 6, 2010
/s/ Douglas E. Robinson
Douglas E. Robinson, Chief Financial Officer
of Verint Systems Inc.
(Principal Financial Officer and Principal Accounting Officer)
July 6, 2010
/s/ Paul D. Baker
Paul D. Baker, Director of Verint Systems Inc.
July 6, 2010
/s/ John Bunyan
John Bunyan, Director of Verint Systems Inc.
July 6, 2010
/s/ Andre Dahan
Andre Dahan, Chairman of the Board of Directors of Verint Systems Inc.
July 6, 2010
/s/ Victor A. DeMarines
Victor A. DeMarines, Director of Verint Systems Inc.
July 6, 2010
/s/ Kenneth A. Minihan
Kenneth A. Minihan, Director of Verint Systems Inc.
July 6, 2010
II-5
Table of Contents
/s/ Larry Myers
Larry Myers, Director of Verint Systems Inc.
July 6, 2010
/s/ Howard Safir
Howard Safir, Director of Verint Systems Inc.
July 6, 2010
/s/ Shefali Shah
Shefali Shah, Director of Verint Systems Inc.
July 6, 2010
/s/ Stephen M. Swad
Stephen M. Swad, Director of Verint Systems Inc.
July 6, 2010
/s/ Lauren Wright
Lauren Wright, Director of Verint Systems Inc.
July 6, 2010
II-6
Table of Contents
EXHIBIT INDEX
Filed Herewith /
Incorporated by Reference
Number
Description
from
4.1
Amended and Restated Certificate of Incorporation of Verint
Systems Inc.
Form S-1 (Commission
File No. 333-82300)
effective on May 16,
2002
4.2
Certificate of Designation, Preferences and Rights of the Series A
Convertible Perpetual Preferred Stock
Form 8-K filed on May
30, 2007 8-K
4.3
Amended and Restated By-laws of Verint Systems Inc.
Form 10-K filed on March 17, 2010
4.4
Specimen Common Stock certificate
Form S-1 (Commission
File No. 333-82300)
effective on May 16,
2002
4.5
Specimen Series A Convertible Perpetual Preferred Stock certificate
Form 10-K filed on March 17, 2010
4.6
Verint Systems Inc. Stock Incentive Compensation Plan (as amended
through December 12, 2002)
Form 10-K filed on May
1, 2003
4.7
Amendment No. 1 to Verint Systems Inc. Stock Incentive
Compensation Plan (dated December 23, 2008)
Form 10-K filed on March 17, 2010
4.8
Amendment No. 2 to Verint Systems Inc. Stock Incentive
Compensation Plan (dated March 4, 2009)
Form 10-K filed on March 17, 2010
4.9
Verint Systems Inc. 2004 Stock Incentive Compensation Plan, as
amended and restated
Form 8-K filed on
January 10, 2006
4.10
Amendment No. 1 to Verint Systems Inc. 2004 Stock Incentive
Compensation Plan, as amended and restated (dated December 23,
2008)
Form 10-K filed on March 17, 2010
4.11
Witness Systems Amended and Restated Stock Incentive Plan
Witness Systems, Inc.
Form 10-Q filed on
August 9, 2005
4.12
Amendment No. 1 to Witness Systems Amended and Restated Stock
Incentive Plan (dated May 29, 2001)
Witness Systems, Inc.
Form 10-K filed on March 17, 2006
4.13
Amendment No. 2 to Witness Systems Amended and Restated Stock
Incentive Plan (dated January 15, 2004)
Witness Systems, Inc.
Form 10-K filed on March 15, 2004
4.14
Amendment No. 3 to Witness Systems Amended and Restated Stock
Incentive Plan (dated December 6, 2007)
Form 10-K filed on March 17, 2010
4.15
Amendment No. 4 to Witness Systems Amended and Restated Stock
Incentive Plan (dated December 23, 2008)
Form 10-K filed on March 17, 2010
5.1
Opinion of Jones Day
Filed Herewith
23.1
Consent of Deloitte & Touche LLP
Filed Herewith
23.2
Consent of Jones Day (included in Exhibit 5.1)
Filed Herewith
II-7